name: Worst Severity Past Seven Days Problems with Tasting Food or Drink Question


name: Worst Severity Past Seven Days Problems with Memory Question


name: Worst Severity Past Seven Days Hoarse Voice Question


name: Worst Severity Past Seven Days Heartburn Question


name: Worst Severity Past Seven Days Feeling Nothing Could Cheer You Up Question


name: Worst Severity Past Seven Days Dry Mouth Question


name: Worst Severity Past Seven Days Difficulty Swallowing Question


name: Worst Severity Past Seven Days Bloating of the Abdomen Question


name: Worst Severity Past Seven Days Anxiety Question


name: Worried About Weight Being Too Low Question


name: Worked in Place Where Other People Smoked Cigarettes Indoors Past 30 Days Question


name: Wolchok Solid Tumors 2009 Oncology Response Criteria


name: Wide Column of Contrast or Air Between Tongue Base and Posterior Pharyngeal Wall During Swallowing


name: Walking Half a Block on Level Ground Question


name: Walking Half Block Uphill Nonstop Question


name: Walking 6 Blocks on Level Ground Question


name: Walking 6 Blocks on Level Ground Nonstop Question


name: Walking 3 Miles or Golfing 18 Holes Without a Riding Cart Question


name: Walking 2 Blocks on Level Ground Question


name: Walking 2 Blocks on Level Ground Nonstop Question


name: Walking 1 Block on Level Ground Question


name: Walking 1 Block on Level Ground Nonstop Question


name: Voice Handicap Index Functional Subscale


name: Clinical Trial Vendor Management Plan Documentation


name: Vector of Transplantation Incompatibility


name: Vacuuming Carpets 5 Minutes Nonstop Ability Question


name: Vacuolated Lymphocyte to Leukocyte Ratio Measurement


name: Using Public Transport or Driving a Car, 99 Miles or Less Question


name: Using Public Transport or Driving a Car, 100 Miles or More Question


name: Used Telephone Help Line or Quit Cigarette Smoking Line


name: Used Support of Friends and Family to Quit Cigarette Smoking


name: Used Quit Tobacco Clinic, Class, or Support Group


name: Used Quit Cigarette Smoking Internet or Web-Based Program


name: Used Quit Cigarette Smoking Books and/or Pamphlets


name: Used Individual or Group Counseling to Quit Cigarette Smoking


name: Unilateral Bulging on Pharyngeal Contraction


name: Uncomfortable with Changes in Body Question


name: Uncomfortable in Certain Positions Question


name: Ultrasound-Guided Near-Infrared Optical Tomography


name: Tsukasaki Leukemia Lymphoma 2009 Oncology Response Criteria


name: Trying to Quit or Stay Off Smoking Cigarettes Past 30 Days Question


name: Extent Troubled with Side Effects from Treatment Question


name: Troubled By Breathlessness Other Than on Strenuous Exertion Question


name: Tricuspid Regurgitant Jet Area to Right Atrial Area Ratio


name: Train Staff about Medication Use Process


name: Trace Residue Within or On Pharyngeal Structures Following Swallowing


name: Trace Column of Contrast or Air Between Tongue Base and Posterior Pharyngeal Wall During Swallowing


name: Trace Column of Contrast or Air Between Soft Palate and Pharyngeal Wall During Swallowing


name: Total Years Have Smoked Cigarettes Question


name: Timely and Efficient Chewing and Mashing


name: Time Spent on Other Aerobic Recreation Question


name: Time Spent Standing or Walking at Work Question


name: Time Spent Standing or Walking at Home Question


name: Time Spent Sitting at Work or While Driving Question


name: Time Spent Running 10 Minutes per Mile or Faster Question


name: Time Spent Playing Tennis, Squash, or Racquetball Question


name: Time Spent Jogging Slower than 10 Minutes per Mile Question


name: Time Spent Doing Calisthenics, Aerobics, Aerobic Dance, Rowing Machine Question


name: Three-Dimensional Echo-Planar Spectroscopic Imaging


name: The Expanded Prostate Cancer Index Composite Short Form Questionnaire


name: Swimming 25 Yards Nonstop Ability Question


name: Supplement to Farooqui CLL 2014 Oncology Response Criteria


name: Study Protocol Uniform Resource Locator Description


name: Risk Evaluation and Mitigation Strategies Terminology


name: Stromal Cell to Total Cell Ratio Measurement


name: Stayed Off Cigarettes Less than One Day Since Diagnosis


name: Stayed Off Cigarettes Entire Time Since Diagnosis


name: Standing for More Than 5 Minutes Question


name: Standing for More Than 1 Minute Question


name: Smoking Products Used Past 30 Days Question


name: Smoking Products Ever Used Regularly Question


name: Smoked at Least 100 Cigarettes in Entire Life (question)


name: Smoked Cigarettes Since Last Visit to This Clinic Question


name: Smoked Cigarettes From Two Days Before Last Cancer Surgery to Two Days After Question


name: Smoked Cigarettes During the Course of Treatment Question


name: Smoked Cigarettes During Year Before First Diagnosed with Cancer Question


name: Smoked Cigarettes After Treatment End Question


name: Smoked Cigarettes After Diagnosis and Before Treatment Start Question


name: Smoked Any Cigarettes Past 30 Days Question


name: Slow Prolonged Chewing or Mashing with Complete Re-Collection


name: Skin and/or Joint Tightening at its Worst Question


name: Single Site European Union State Trial Indicator


name: Shoveling, Digging, or Spading 5 Minutes Nonstop Question


name: Short of Breath When Hurrying on Level Ground or Walking Up a Slight Hill Question


name: Shindoh Colorectal Cancer 2013 Oncology Response Criteria


name: Sharp van der Heijde Joint Space Narrowing Score


name: Sharp Genant Joint Space Narrowing Score


name: Semmes Weinstein Monofilament Examination


name: Segmented Granulocyte to Total Cell Ratio Measurement


name: Scrubbing Doors, Walls, or Cars Question


name: Schwarz Cervical Cancer 2009 Oncology Response Criteria


name: Satisfaction with Overall Sexual Life Question


name: Satisfaction of Sexual Relationship with Partner Question


name: Satisfaction of Emotional Closeness During Sexual Activity with Partner Question


name: Satisfaction of Ability to Reach Orgasm During Sexual Activity or Intercourse Question


name: SUSAR Reporting to National Competent Authority Indicator


name: SUSAR Reporting to EudraVigiliance Clinical Trial Module Indicator


name: Running or Jogging 3 Miles in 30 Minutes or Less Question


name: Running or Jogging 2 Miles in 20 Minutes or Less Question


name: Running or Jogging 1/4 Mile Nonstop Question


name: Running or Jogging 1/2 Mile Nonstop Question


name: Running or Jogging 1 Mile in 12 Minutes or Less Question


name: Running 110 Yards or Playing Softball or Baseball Question


name: Rubricyte to Total Cell Ratio Measurement


name: Review Healthcare Training or Educational Materials


name: Restricted in the Types of Food You Can Eat as a Result of Disease or Treatment Question


name: Restricted in the Amount of Food You Can Eat as a Result of Disease or Treatment Question


name: Resting State Functional Connectivity Magnetic Resonance Imaging


name: Residue on Valleculae Following Swallowing


name: Residue on Pyriform Sinuses Following Swallowing


name: Residue on Aryepiglottic Folds Following Swallowing


name: Requires Secure Email Delivery of XML Indicator


name: Repetitive or Disorganized Tongue Motion


name: Rajkumar Myeloma 2011 Oncology Response Criteria


name: Quality of Life Questionnaire - Pancreatic Cancer 26


name: Quality of Life Questionnaire - Chemotherapy-Induced Peripheral Neuropathy 20 Items


name: Putting on Shoes, Stockings, or Socks Without Rest or a Break Question


name: Pulmonic Regurgitant Jet Width to Right Ventricular Outflow Tract Diameter Ratio


name: Protein Interaction Domain Inhibitor Therapy


name: Prostate Cancer Specific Quality of Life Instrument Questionnaire


name: Prorubricyte to Total Cell Ratio Measurement


name: Proliferating Myeloid Cell to Total Cell Ratio Measurement


name: Proliferating Erythroid Cell to Total Cell Ratio Measurement


name: Products Used to Quit or Stay Off Smoking Cigarettes Since Diagnosis Question


name: Products Used to Quit or Stay Off Smoking Cigarettes Past 30 Days Question


name: Tobacco Products Used Regularly Since Cancer Diagnosis Question


name: Prince T Cell Lymphoma 2010 Oncology Response Criteria


name: Posterior Escape of Less Than Half of Bolus


name: Posterior Escape of Greater Than Half of Bolus


name: Playing a Basketball or Soccer Game Question


name: Plasma Cells to Leukocytes Ratio Measurement


name: Pharyngeal Stripping Wave Present but Diminished


name: Pharyngeal Stripping Wave Present and Complete


name: Petit Breast Cancer 2001 Oncology Response Criteria


name: Percent Predicted Functional Residual Capacity


name: Percent Change From Nadir in Sum of Area


name: Perceived Stress Scale - 14 Questionnaire


name: Pediatric Infectious Disease Terminology


name: Patient Health Questionnaire Screener Version


name: Past Seven Days Sad or Unhappy Feelings Interfering with Usual or Daily Activities Question


name: Past Seven Days Ridges or Bumps on Fingernails or Toenails Question


name: Past Seven Days Problems with Memory Interfering with Usual or Daily Activities Question


name: Past Seven Days Mouth or Throat Sores Interfering with Usual or Daily Activities Question


name: Past Seven Days Loss of Fingernails or Toenails Question


name: Past Seven Days Increased Skin Sensitivity to Sunlight Question


name: Past Seven Days Increased Passing of Gas Question


name: Past Seven Days Frequency of Sad or Unhappy Feelings Question


name: Past Seven Days Frequency of Heartburn Question


name: Past Seven Days Frequency of Feeling Nothing Could Cheer You Up Question


name: Past Seven Days Frequency of Bloating of the Abdomen Question


name: Past Seven Days Frequency of Anxiety Question


name: Past Seven Days Feeling Nothing Could Cheer You Up Interfering with Usual or Daily Activities Question


name: Past Seven Days Color Change of Fingernails or Toenails Question


name: Past Seven Days Anxiety Interfering with Usual or Daily Activities Question


name: Participate in Social Activities Question


name: Partial Superior Movement of Thyroid Cartilage with Minimal Approximation of Arytenoids to Epiglottic Petiole During Swallowing


name: Partial Superior Movement of Thyroid Cartilage During Swallowing


name: Partial Inversion of Epiglottis During Swallowing


name: Partial Distension or Partial Duration of Pharyngoesophageal Segment Opening During Swallowing


name: Partial Anterior Movement of Hyoid During Swallowing


name: Palumbo Multiple Myeloma 2009 Oncology Response Criteria


name: PROSQOLI - Enjoying Time with Friends and Family


name: PHQ Screener Version Questionnaire Question


name: PHQ Screener Version - Thoughts Be Better Off Dead


name: PHQ Screener Version - Shortness of Breath


name: PHQ Screener Version - Problems Made It Difficult to Work


name: PHQ Screener Version - Problem Getting Along With People While Drinking


name: PHQ Screener Version - Poor Appetite or Overeating


name: PHQ Screener Version - Pain in Arms, Legs, Joints


name: PHQ Screener Version - Pain During Intercourse


name: PHQ Screener Version - Often Eat Large Amount Food


name: PHQ Screener Version - No Control What or How Much Eat


name: PHQ Screener Version - Nausea, Gas or Indigestion


name: PHQ Screener Version - Moving Slowly or Moving More


name: PHQ Screener Version - Missed Work Because of Drinking


name: PHQ Screener Version - Menstrual Cramp or Other Problem


name: PHQ Screener Version - Little Interest in Doing Things


name: PHQ Screener Version - Last 4 Weeks, Trouble Falling or Staying Asleep


name: PHQ Screener Version - Last 4 Weeks, Trouble Concentrating


name: PHQ Screener Version - Last 2 Weeks, Trouble Falling or Staying Asleep


name: PHQ Screener Version - Last 2 Weeks, Trouble Concentrating


name: PHQ Screener Version - Getting Tired Easily


name: PHQ Screener Version - Feeling Your Heart Pound or Race


name: PHQ Screener Version - Feeling Tired or Little Energy


name: PHQ Screener Version - Feeling Nervous or Anxious


name: PHQ Screener Version - Feeling Down or Depressed


name: PHQ Screener Version - Feeling Bad About Yourself


name: PHQ Screener Version - Eat a Lot Twice Week


name: PHQ Screener Version - Drove Car After Several Drinks


name: PHQ Screener Version - Drank Alcohol at Work or School


name: PHQ Screener Version - Drank Alcohol With Health Problem


name: PHQ Screener Version - Constipation or Diarrhea


name: PHQ Screener Version - Becoming Easily Annoyed


name: PHQ Screener Version - Avoid Gaining Weight, Took Twice Dose of Laxatives


name: PHQ Screener Version - Avoid Gaining Weight, Made Yourself Vomit


name: PHQ Screener Version - Avoid Gaining Weight, Fasted at Least 24 Hours


name: PHQ Screener Version - Avoid Gaining Weight, Exercise


name: PHQ Screener Version - Avoid Gaining Weight Twice Week


name: PHQ Screener Version - Anxiety Attacks Come Suddenly


name: PHQ Screener Version - Anxiety Attacks Bother a Lot


name: PHQ Screener Version - Anxiety Attack Tremble or Shake


name: PHQ Screener Version - Anxiety Attack Tingling or Numbness


name: PHQ Screener Version - Anxiety Attack Sweat


name: PHQ Screener Version - Anxiety Attack Short of Breath


name: PHQ Screener Version - Anxiety Attack Nausea or Diarrhea


name: PHQ Screener Version - Anxiety Attack Hot Flash or Chill


name: PHQ Screener Version - Anxiety Attack Heart Race or Pound


name: PHQ Screener Version - Anxiety Attack Happened Before


name: PHQ Screener Version - Anxiety Attack Dizzy or Faint


name: PHQ Screener Version - Anxiety Attack Choking


name: PHQ Screener Version - Anxiety Attack Chest Pain


name: PHQ Screener Version - Anxiety Attack Afraid You Were Dying


name: PCWG Scher Prostate Cancer 2008 Oncology Response Criteria


name: PCWG Bubley Prostate Cancer 1999 Oncology Response Criteria


name: Other Smoking Products Used Past 30 Days Question


name: Other Smoking Products Ever Used Regularly Question


name: Other Products Used Regularly Since Cancer Diagnosis Question


name: Clinical Trial Submission to Other Committees Documentation


name: Observational Study Sampling Method Description


name: Observational Study Population Description


name: Observational Medical Outcomes Partnership


name: Nurses' Health Study II Activity and Inactivity Questionnaire


name: Number of Years Stayed Off Cigarettes Question


name: Number of Years Since Last Cigarette Question


name: Number of Weeks Stayed Off Cigarettes Question


name: Number of Weeks Since Last Cigarette Question


name: Number of Trial Sites within European Union State


name: Number of Months Since Last Cigarette Question


name: Number of Days Stayed Off Cigarettes Question


name: Number of Days Smoked Cigarettes Past 30 Days Question


name: Number of Days Since Last Cigarette Question


name: Non-Prescribing Non-Dispensing Healthcare Provider


name: No Visible Posterior Motion of Tongue Base During Swallowing


name: No Visible Initiation of Pharyngeal Swallow at Any Location


name: No Superior Movement of Thyroid Cartilage During Swallowing


name: No Inversion of Epiglottis During Swallowing


name: No Distension of Pharyngoesophageal Segment Opening During Swallowing


name: No Contrast Between Tongue Base and Posterior Pharyngeal Wall During Swallowing


name: No Bolus Between Soft Palate/Pharyngeal Wall During Swallowing


name: No Anterior Movement of Hyoid During Swallowing


name: National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Prostate Symptom Index 17 Version 2 Questionnaire


name: National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Ovarian Symptom Index-18 Version 2 Questionnaire


name: National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Kidney Symptom Index-19 Version 2 Questionnaire


name: National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Bladder Symptom Index-18 Version 2 Questionnaire


name: Narrow Column of Contrast or Air Between Tongue Base and Posterior Pharyngeal Wall During Swallowing


name: NCIWG Cheson CLL 1996 Oncology Response Criteria


name: NCCN-FACT-FPSI 17 Version 2 Questionnaire Question


name: NCCN-FACT-FPSI 17 Version 2 - Worry My Condition Will Get Worse


name: NCCN-FACT-FPSI 17 Version 2 - Pain Keeps Me From Doing Things


name: NCCN-FACT-FPSI 17 Version 2 - I Have a Lack of Energy


name: NCCN-FACT-FPSI 17 Version 2 - I Have a Good Appetite


name: NCCN-FACT-FPSI 17 Version 2 - I Have Weakness in My Legs


name: NCCN-FACT-FPSI 17 Version 2 - I Have Trouble Moving My Bowels


name: NCCN-FACT-FPSI 17 Version 2 - I Have Pain


name: NCCN-FACT-FPSI 17 Version 2 - I Have Nausea


name: NCCN-FACT-FPSI 17 Version 2 - I Have Difficulty Urinating


name: NCCN-FACT-FPSI 17 Version 2 - I Have Bone Pain


name: NCCN-FACT-FPSI 17 Version 2 - I Feel Fatigued


name: NCCN-FACT-FPSI 17 Version 2 - I Am Sleeping Well


name: NCCN-FACT-FPSI 17 Version 2 - I Am Satisfied With My Sex Life


name: NCCN-FACT-FPSI 17 Version 2 - I Am Losing Weight


name: NCCN-FACT-FPSI 17 Version 2 - I Am Able to Enjoy Life


name: NCCN-FACT-FPSI 17 Version 2 - Content With Quality of My Life


name: NCCN-FACT-FPSI 17 Version 2 - Bothered by Treatment Side Effect


name: NCCN-FACT FOSI-18 Version 2 Questionnaire Question


name: NCCN-FACT FOSI-18 Version 2 - Worry My Condition Will Get Worse


name: NCCN-FACT FOSI-18 Version 2 - I Have a Lack of Energy


name: NCCN-FACT FOSI-18 Version 2 - I Have Swelling in Stomach Area


name: NCCN-FACT FOSI-18 Version 2 - I Have Pain


name: NCCN-FACT FOSI-18 Version 2 - I Have Nausea


name: NCCN-FACT FOSI-18 Version 2 - I Have Cramps in My Stomach Area


name: NCCN-FACT FOSI-18 Version 2 - I Have Control of My Bowels


name: NCCN-FACT FOSI-18 Version 2 - I Have Been Vomiting


name: NCCN-FACT FOSI-18 Version 2 - I Feel Ill


name: NCCN-FACT FOSI-18 Version 2 - I Feel Fatigued


name: NCCN-FACT FOSI-18 Version 2 - I Am Sleeping Well


name: NCCN-FACT FOSI-18 Version 2 - I Am Bothered by Skin Problems


name: NCCN-FACT FOSI-18 Version 2 - I Am Bothered by Hair Loss


name: NCCN-FACT FOSI-18 Version 2 - I Am Bothered by Constipation


name: NCCN-FACT FOSI-18 Version 2 - I Am Able to Get Around by Myself


name: NCCN-FACT FOSI-18 Version 2 - I Am Able to Enjoy Life


name: NCCN-FACT FOSI-18 Version 2 - Content With Quality of My Life


name: NCCN-FACT FOSI-18 Version 2 - Bothered by Treatment Side Effect


name: NCCN-FACT FKSI-19 Version 2 - Worry My Condition Will Get Worse


name: NCCN-FACT FKSI-19 Version 2 - I Have a Lack of Energy


name: NCCN-FACT FKSI-19 Version 2 - I Have a Good Appetite


name: NCCN-FACT FKSI-19 Version 2 - I Have Pain


name: NCCN-FACT FKSI-19 Version 2 - I Have Nausea


name: NCCN-FACT FKSI-19 Version 2 - I Have Had Blood in My Urine


name: NCCN-FACT FKSI-19 Version 2 - I Have Diarrhea


name: NCCN-FACT FKSI-19 Version 2 - I Have Bone Pain


name: NCCN-FACT FKSI-19 Version 2 - I Have Been Short of Breath


name: NCCN-FACT FKSI-19 Version 2 - I Have Been Coughing


name: NCCN-FACT FKSI-19 Version 2 - I Feel Weak All Over


name: NCCN-FACT FKSI-19 Version 2 - I Feel Fatigued


name: NCCN-FACT FKSI-19 Version 2 - I Am Sleeping Well


name: NCCN-FACT FKSI-19 Version 2 - I Am Losing Weight


name: NCCN-FACT FKSI-19 Version 2 - I Am Bothered by Fevers


name: NCCN-FACT FKSI-19 Version 2 - I Am Able to Work


name: NCCN-FACT FKSI-19 Version 2 - I Am Able to Enjoy Life


name: NCCN-FACT FKSI-19 Version 2 - Content With Quality of My Life


name: NCCN-FACT FKSI-19 Version 2 - Bothered by Treatment Side Effect


name: NCCN-FACT FBLSI-18 Version 2 Questionnaire Question


name: NCCN-FACT FBLSI-18 Version 2 - Worry My Condition Will Get Worse


name: NCCN-FACT FBLSI-18 Version 2 - Trouble Meeting Needs of Family


name: NCCN-FACT FBLSI-18 Version 2 - I Have a Lack of Energy


name: NCCN-FACT FBLSI-18 Version 2 - I Have a Good Appetite


name: NCCN-FACT FBLSI-18 Version 2 - I Have Pain


name: NCCN-FACT FBLSI-18 Version 2 - I Have Nausea


name: NCCN-FACT FBLSI-18 Version 2 - I Have Control of My Bowels


name: NCCN-FACT FBLSI-18 Version 2 - I Feel Weak All Over


name: NCCN-FACT FBLSI-18 Version 2 - I Feel Sad


name: NCCN-FACT FBLSI-18 Version 2 - I Feel Light-headed


name: NCCN-FACT FBLSI-18 Version 2 - I Feel Ill


name: NCCN-FACT FBLSI-18 Version 2 - I Am Sleeping Well


name: NCCN-FACT FBLSI-18 Version 2 - I Am Losing Weight


name: NCCN-FACT FBLSI-18 Version 2 - I Am Able to Enjoy Life


name: NCCN-FACT FBLSI-18 Version 2 - Have Trouble Controlling My Urine


name: NCCN-FACT FBLSI-18 Version 2 - Content With Quality of My Life


name: NCCN-FACT FBLSI-18 Version 2 - Bothered by Treatment Side Effect


name: NCCN-FACT FBLSI-18 Version 2 - Able to Have, Maintain Erection


name: NCCN ALL MRD 2014 Oncology Response Criteria


name: Murphy Prostate Cancer 1980 Oncology Response Criteria


name: Multiple Site European Union State Trial Indicator


name: Mowing The Lawn with a Power Mower Question


name: Montserrat CLL 1989 Oncology Response Criteria


name: Modified RECIST Lencioni Liver Cancer 2010 Oncology Response Criteria


name: Modified RECIST Byrne Mesothelioma 2004 Oncology Response Criteria


name: Modified RANO Van Den Bent Glioma 2011 Oncology Response Criteria


name: Modified Barium Swallow Impairment Profile


name: Mitral Regurgitant Jet Area to Left Atrial Area Ratio


name: Minor Axis Cross-sectional Diameter at End Ventricular Systole


name: Minor Axis Cross-sectional Diameter at End Ventricular Diastole


name: Minkov Langerhans Cell Histiocytosis 2009 Oncology Response Criteria


name: Minimal to No Pharyngeal Clearance Following Swallowing


name: Minimal to No Esophageal Clearance Following Swallowing


name: Minimal Distension or Minimal Duration of Pharyngoesophageal Segment Opening During Swallowing


name: Minimal Chewing or Mashing with Majority of Bolus Unchewed


name: Metarubricyte to Total Cell Ratio Measurement


name: Medical Research Council Breathlessness Score


name: Maturing Erythroid Cell to Total Cell Ratio Measurement


name: Making a Bed and Changing Sheets Question


name: Majority of Contrast Within or On Pharyngeal Structures Following Swallowing


name: Major Axis Cross-sectional Diameter at End Ventricular Systole


name: Major Axis Cross-sectional Diameter at End Ventricular Diastole


name: Macdonald Glioma 1990 Oncology Response Criteria


name: MRI-Guided Transurethral Ultrasound Ablation


name: Lugano Classification Oncology Response Criteria


name: Lost a Lot of Weight Without Trying Question


name: Lost Interest in Usual Activities Question


name: Longest Time Stayed off Cigarettes Since Cancer Diagnosis Question


name: Lived in Place Where Other People Smoked Cigarettes Indoors Past 30 Days Question


name: Level of Sexual Desire or Interest Question


name: Level of Sexual Arousal During Sexual Activity or Intercourse Question


name: Level of Discomfort or Pain During or Following Vaginal Penetration Question


name: Left Ventricular Outflow Tract Velocity Time Integral


name: Left Ventricular Outflow Tract Peak Velocity


name: Lee Lung Cancer 2011 Oncology Response Criteria


name: Largest Cross-sectional Diameter at End Ventricular Diastole


name: Kuker Lymphoma 2005 Oncology Response Criteria


name: Kneeling or Squatting to Do Light Work Question


name: Kimby Waldenstroms Macroglobulinemia 2006 Oncology Response Criteria


name: Keam Breast Cancer 2013 Oncology Response Criteria


name: Juweid Non-Hodgkins Lymphoma 2005 Oncology Response Criteria


name: Joints and Fascia Complete Response GvHD


name: Japanese Classification Gastric Cancer 2011 Oncology Response Criteria


name: Jacinto Cervical Cancer 2007 Oncology Response Criteria


name: Interlabial Escape; No Progression to Anterior Lip


name: Institutional Review Board Independent Ethics Committee Progress Report Documentation


name: Initiation of Pharyngeal Swallow with Bolus Head in Valleculae


name: Initiation of Pharyngeal Swallow with Bolus Head in Pyriform Sinus


name: Initiation of Pharyngeal Swallow with Bolus Head at Posterior Angle of Ramus


name: Initiation of Pharyngeal Swallow with Bolus Head at Posterior Laryngeal Surface of Epiglottis


name: Impairment of Tongue Control During Bolus Hold


name: Impairment of Pharyngoesophageal Segment Opening


name: Impairment of Laryngeal Vestibular Closure, Height of Swallow


name: Impairment of Esophageal Clearance Following Swallowing in Upright Position


name: Impairment of Bolus Transport or Lingual Motion


name: Impairment of Bolus Preparation or Mastication


name: Immature Leukocyte to Leukocytes Ratio Measurement


name: IWG Cheson MDS 2000 Oncology Response Criteria


name: IWG Cheson AML 2003 Oncology Response Criteria


name: IWC Hallek CLL 2008 Oncology Response Criteria


name: Human Papillomavirus 6 Antibody Measurement


name: Human Papillomavirus 18 Antibody Measurement


name: Human Papillomavirus 16 Antibody Measurement


name: Human Papillomavirus 11 Antibody Measurement


name: Age When First Smoked a Cigarette Question


name: How Old When First Began Smoking Cigarettes Regularly Question


name: How Often Found Yourself Thinking About Things That You Have to Accomplish in the Last Month Question


name: How Often Felt You Were Effectively Coping with Important Changes Occurring in Life Question


name: How Often Dealt Successfully with Day to Day Problems and Annoyances in the Last Month Question


name: How Often Able to Control the Way You Spend Your Time in the Last Month Question


name: How Much Shortness of Breath During Activity Question


name: Have to Walk Slower Than Most People on Level Ground Question


name: Have to Stop for Breath After Walking About 100 Yards on Level Ground Question


name: Have to Stop After Walking a Mile, or After One Quarter Hour, on Level Ground at Own Pace Question


name: Have a Lot of Trouble Getting to Sleep Question


name: Have Shooting or Burning Pain in Toes or Feet Question


name: Have Shooting or Burning Pain in Fingers or Hands Question


name: Have Problems Standing or Walking Because of Difficulty Feeling the Ground Under Feet Question


name: Have Necessary Healthcare Personnel or Equipment


name: Have Difficulty Walking Because Feet Drop Downwards Question


name: Have Difficulty Using Car Pedals Question


name: Have Difficulty Opening a Jar or Bottle Because of Weakness in Hands Question


name: Have Difficulty Manipulating Small Objects with Fingers Question


name: Have Difficulty Distinguishing Between Hot and Cold Water Question


name: Have Difficulty Climbing Stairs or Getting Out of Chair Because of Weakness in Legs Question


name: Hartman Pancreatic Cancer 2012 Oncology Response Criteria


name: Hartmann Germ Cell Cancer 2002 Oncology Response Criteria


name: Hamaoka Breast Cancer 2010 Oncology Response Criteria


name: HLA-A2-restricted IL-13Ra2/EphA2/Survivin/Tetanus Toxoid T-helper Epitopes-Montanide 51 Vaccine


name: HLA Class II Panel Reactive Antibody Measurement


name: HLA Class I Panel Reactive Antibody Measurement


name: Guppy Ovarian Cancer 2002 Oncology Response Criteria


name: Guilhot CML 2007 Oncology Response Criteria


name: Guidelines for Management of Breast Cancer WHO 2006


name: Gluten-free DHA/EPA/GLA/Antioxidant-rich Nutritional Liquid


name: Estimated Glomeluar Filtration Rate from Cystatin C and Creatinine Adjusted for Standard BSA


name: Getting In or Out of a Car Without Assistance Question


name: Getting In and Out of Chairs or Bed Without Assistance Question


name: Getting Clothes from Drawers or Closets Question


name: Genital Discomfort at its Worst Question


name: GCIG Rustin Ovarian Cancer 2011 Oncology Response Criteria


name: GAIA Stillbirth Level of Diagnostic Certainty


name: GAIA Stillbirth Level of Diagnostic Certainty Terminology


name: GAIA Spontaneous Abortion and Ectopic Pregnancy Level of Diagnostic Certainty


name: GAIA Spontaneous Abortion and Ectopic Pregnancy Level of Diagnostic Certainty Terminology


name: GAIA Spontaneous Abortion Level of Diagnostic Certainty


name: GAIA Small for Gestational Age Level of Diagnostic Certainty


name: GAIA Small for Gestational Age Level of Diagnostic Certainty Terminology


name: GAIA Provider Initiated Preterm Delivery Levels of Diagnostic Certainty


name: GAIA Preterm Labor Levels of Diagnostic Certainty


name: GAIA Preterm Birth Level of Diagnostic Certainty


name: GAIA Preterm Birth Level of Diagnostic Certainty Terminology


name: GAIA Prenatally Diagnosed Congenital Microcephaly Level of Diagnostic Certainty


name: GAIA Premature Preterm Rupture of Membranes Levels of Diagnostic Certainty


name: GAIA Insufficient Evidence for Diagnosis of Preeclampsia


name: GAIA Preeclampsia Level of Diagnostic Certainty


name: GAIA Preeclampsia Level of Diagnostic Certainty Terminology


name: GAIA Postpartum Hemorrhage Level of Diagnostic Certainty


name: GAIA Postpartum Hemorrhage Level of Diagnostic Certainty Terminology


name: GAIA Postnatally Diagnosed Congenital Microcephaly Level of Diagnostic Certainty


name: GAIA Pathways to Preterm Birth Level of Diagnostic Certainty


name: GAIA Pathways to Preterm Birth Level of Diagnostic Certainty Terminology


name: GAIA Non-Reassuring Fetal Status Level of Diagnostic Certainty


name: GAIA Non-Reassuring Fetal Status Level of Diagnostic Certainty Terminology


name: GAIA Neonatal Respiratory Distress Level of Diagnostic Certainty


name: GAIA Neonatal Respiratory Distress Level of Diagnostic Certainty Terminology


name: GAIA Neonatal Infections Level of Diagnostic Certainty


name: GAIA Neonatal Infections Level of Diagnostic Certainty Terminology


name: GAIA Neonatal Death Level of Diagnostic Certainty


name: GAIA Neonatal Death Level of Diagnostic Certainty Terminology


name: GAIA Maternal Immunization Level of Diagnostic Certainty


name: GAIA Maternal Death Level of Diagnostic Certainty


name: GAIA Maternal Death Level of Diagnostic Certainty Terminology


name: GAIA Major Congenital Anomalies Level of Diagnostic Certainty


name: GAIA Major Congenital Anomalies Level of Diagnostic Certainty Terminology


name: GAIA Low Birth Weight Level of Diagnostic Certainty


name: GAIA Low Birth Weight Level of Diagnostic Certainty Terminology


name: GAIA Level 4 Second Trimester Spontaneous Abortion


name: GAIA Level 4 Prenatally Diagnosed Congenital Microcephaly


name: GAIA Level 4 Postnatally Diagnosed Congenital Microcephaly


name: GAIA Level 4 Major Internal Structural Defect


name: GAIA Level 4 Major External Structural Defect


name: GAIA Level 4 First Trimester Spontaneous Abortion


name: GAIA Level 3b Neonatal Infectious Meningitis


name: GAIA Level 3a Neonatal Infectious Meningitis


name: GAIA Level 3b Assessment of Gestational Age


name: GAIA Level 3a Assessment of Gestational Age


name: GAIA Level 3 Non-reassuring Fetal Status


name: GAIA Level 3 Neonatal Respiratory Tract Infection


name: GAIA Level 3 Neonatal Invasive Bloodstream Infection


name: GAIA Level 3 Neonatal Death in an Extremely Preterm Live Birth


name: GAIA Level 3 Neonatal Death in a Term Live Birth


name: GAIA Level 3 Neonatal Death in a Preterm Live Birth


name: GAIA Level 3 Neonatal Death in a Non-viable Live Birth


name: GAIA Level 3 Major Internal Structural Defect


name: GAIA Level 3 Major External Structural Defect


name: GAIA Level 3 Gestational Diabetes Mellitus


name: GAIA Level 3 First Trimester Spontaneous Abortion


name: GAIA Level 3 Assessment of Provider Initiated Preterm Delivery


name: GAIA Level 3 Assessment of Preterm Labor


name: GAIA Level 3 Assessment of Premature Preterm Rupture of Membranes


name: GAIA Level 3 Assessment of Insufficient Cervix


name: GAIA Level 2b Postnatally Diagnosed Congenital Microcephaly


name: GAIA Level 2b Assessment of Gestational Age


name: GAIA Level 2a Postnatally Diagnosed Congenital Microcephaly


name: GAIA Level 2a Assessment of Gestational Age


name: GAIA Level 2 Second Trimester Spontaneous Abortion


name: GAIA Level 2 Prenatally Diagnosed Congenital Microcephaly


name: GAIA Level 2 Preeclampsia with Severe Features


name: GAIA Level 2 Non-reassuring Fetal Status


name: GAIA Level 2 Neonatal Respiratory Tract Infection


name: GAIA Level 2 Neonatal Respiratory Distress


name: GAIA Level 2 Neonatal Invasive Bloodstream Infection


name: GAIA Level 2 Neonatal Infectious Meningitis


name: GAIA Level 2 Neonatal Death in an Extremely Preterm Live Birth


name: GAIA Level 2 Neonatal Death in a Term Live Birth


name: GAIA Level 2 Neonatal Death in a Preterm Live Birth


name: GAIA Level 2 Neonatal Death in a Non-viable Live Birth


name: GAIA Level 2 Morbidly Adherent Placentation


name: GAIA Level 2 Major Internal Structural Defect


name: GAIA Level 2 Major External Structural Defect


name: GAIA Level 2 Gestational Diabetes Mellitus


name: GAIA Level 2 First Trimester Spontaneous Abortion


name: GAIA Level 2 Dysfunctional Second Stage of Labor


name: GAIA Level 2 Dysfunctional First Stage of Labor


name: GAIA Level 2 Assessment of Provider Initiated Preterm Delivery


name: GAIA Level 2 Assessment of Preterm Labor


name: GAIA Level 2 Assessment of Premature Preterm Rupture of Membranes


name: GAIA Level 2 Assessment of Insufficient Cervix


name: GAIA Level 1b Prenatally Diagnosed Congenital Microcephaly


name: GAIA Level 1a Prenatally Diagnosed Congenital Microcephaly


name: GAIA Level 1 Second Trimester Spontaneous Abortion


name: GAIA Level 1 Preeclampsia with Severe Features


name: GAIA Level 1 Postnatally Diagnosed Congenital Microcephaly


name: GAIA Level 1 Non-reassuring Fetal Status


name: GAIA Level 1 Neonatal Respiratory Tract Infection


name: GAIA Level 1 Neonatal Respiratory Distress


name: GAIA Level 1 Neonatal Invasive Bloodstream Infection


name: GAIA Level 1 Neonatal Infectious Meningitis


name: GAIA Level 1 Neonatal Death in an Extremely Preterm Live Birth


name: GAIA Level 1 Neonatal Death in a Term Live Birth


name: GAIA Level 1 Neonatal Death in a Preterm Live Birth


name: GAIA Level 1 Neonatal Death in a Non-viable Live Birth


name: GAIA Level 1 Morbidly Adherent Placentation


name: GAIA Level 1 Major Internal Structural Defect


name: GAIA Level 1 Major External Structural Defect


name: GAIA Level 1 Gestational Diabetes Mellitus


name: GAIA Level 1 First Trimester Spontaneous Abortion


name: GAIA Level 1 Dysfunctional Second Stage of Labor


name: GAIA Level 1 Dysfunctional First Stage of Labor


name: GAIA Level 1 Assessment of Provider Initiated Preterm Delivery


name: GAIA Level 1 Assessment of Preterm Labor


name: GAIA Level 1 Assessment of Premature Preterm Rupture of Membranes


name: GAIA Level 1 Assessment of Gestational Age


name: GAIA Insufficient Evidence for Diagnosis of Gestational Diabetes Mellitus


name: GAIA Insufficient Evidence for Diagnosis of Preeclampsia with Severe Features


name: GAIA Insufficient Cervix Levels of Diagnostic Certainty


name: GAIA Insufficient Evidence for Diagnosis of Gestational Hypertension


name: GAIA Gestational Diabetes Mellitus Level of Diagnostic Certainty


name: GAIA Gestational Diabetes Mellitus Level of Diagnostic Certainty Terminology


name: GAIA Gestational Age Levels of Diagnostic Certainty


name: GAIA Fetal Growth Restriction Level of Diagnostic Certainty


name: GAIA Fetal Growth Restriction Level of Diagnostic Certainty Terminology


name: GAIA Failure to Thrive Level of Diagnostic Certainty


name: GAIA Failure to Thrive Level of Diagnostic Certainty Terminology


name: GAIA Ectopic Pregnancy Level of Diagnostic Certainty


name: GAIA Dysfunctional Labor Level of Diagnostic Certainty


name: GAIA Congenital Microcephaly Level of Diagnostic Certainty


name: GAIA Congenital Microcephaly Level of Diagnostic Certainty Terminology


name: GAIA Antenatal Bleeding Level of Diagnostic Certainty


name: GAIA Antenatal Bleeding Level of Diagnostic Certainty Terminology


name: Functional Assessment of Cancer Therapy-Prostate Version 4 Questionnaire


name: Functional Assessment of Cancer Therapy-Ovarian Symptom Index Questionnaire


name: Functional Assessment of Cancer Therapy-Breast Version 4 Questionnaire


name: Frequency of Sexual Desire or Interest Question


name: Frequency of Sexual Arousal During Sexual Activity or Intercourse Question


name: Frequency of Satisfaction with Arousal During Sexual Activity or Intercourse Question


name: Frequency of Reaching Orgasm with Sexual Stimulation or Intercourse Question


name: Frequency of Lubrication During Sexual Activity or Intercourse Question


name: Frequency of Experiencing Discomfort or Pain Following Vaginal Penetration Question


name: Frequency of Experiencing Discomfort or Pain During Vaginal Penetration Question


name: Frequency in Maintenance of Lubrication Until Completion of Sexual Activity or Intercourse Question


name: Free Testosterone to Total Protein Ratio Measurement


name: Frameless Fractionated Stereotactic Radiation Therapy


name: Food and Drink Taste Different from Usual Question


name: Flights of Stairs Climbed Daily Question


name: Feel in Complete Control of Breathing Problems Question


name: Feel Very Confident Can Deal with Illness Question


name: Feel Urge to Move Bowels Quickly Question


name: Feel Upset, Worried, or Depressed Question


name: Feel Upset or Scared When Having Difficulty Getting Breath Question


name: Feel Restless, Tense, or Uptight Question


name: Feel Relaxed and Free of Tension Question


name: Feel Fear or Panic When Difficult to Get Breath Question


name: Feel Discouraged or Down in Dumps Question


name: FOSI - Worry My Condition Will Get Worse


name: FACT-P Version 4 - Worry My Condition Will Get Worse


name: FACT-P Version 4 - Satisfied With How I Am Coping


name: FACT-P Version 4 - Satisfied With Family Communication


name: FACT-P Version 4 - Satisfied With Comfort Level


name: FACT-P Version 4 - Problem Urinating Limits Activity


name: FACT-P Version 4 - Pain Keeps Me From Doing Things


name: FACT-P Version 4 - My Work Is Fulfilling


name: FACT-P Version 4 - My Family Has Accepted My Illness


name: FACT-P Version 4 - Losing Hope Against Illness


name: FACT-P Version 4 - I Urinate More Frequently


name: FACT-P Version 4 - I Have a Lack of Energy


name: FACT-P Version 4 - I Have a Good Appetite


name: FACT-P Version 4 - I Have Trouble Moving My Bowels


name: FACT-P Version 4 - I Have Difficulty Urinating


name: FACT-P Version 4 - I Have Accepted My Illness


name: FACT-P Version 4 - I Get Support From My Friends


name: FACT-P Version 4 - I Feel Close to My Partner


name: FACT-P Version 4 - I Feel Close to My Friends


name: FACT-P Version 4 - I Am Satisfied With My Sex Life


name: FACT-P Version 4 - I Am Forced to Spend Time in Bed


name: FACT-P Version 4 - I Am Able to Feel Like a Man


name: FACT-P Version 4 - I Am Able to Enjoy Life


name: FACT-P Version 4 - Have Aches and Pains That Bother Me


name: FACT-P Version 4 - Get Emotional Support From Family


name: FACT-P Version 4 - Enjoy Things I Usually Do for Fun


name: FACT-P Version 4 - Content With Quality of My Life


name: FACT-P Version 4 - Certain Parts of Body Experience Pain


name: FACT-P Version 4 - Bothered by Treatment Side Effect


name: FACT-P Version 4 - Able to Have and Maintain an Erection


name: FACT-G Version 4 - Worry My Condition Will Get Worse


name: FACT-G Version 4 - Trouble Meeting Needs of Family


name: FACT-G Version 4 - Satisfied With How I Am Coping With Illness


name: FACT-G Version 4 - Satisfied With Family Communication


name: FACT-G Version 4 - My Work Is Fulfilling


name: FACT-G Version 4 - My Family Has Accepted My Illness


name: FACT-G Version 4 - Losing Hope Against Illness


name: FACT-G Version 4 - I Have a Lack of Energy


name: FACT-G Version 4 - I Have Accepted My Illness


name: FACT-G Version 4 - I Get Support From My Friends


name: FACT-G Version 4 - I Get Emotional Support From My Family


name: FACT-G Version 4 - I Feel Close to My Partner


name: FACT-G Version 4 - I Feel Close to My Friends


name: FACT-G Version 4 - I Am Satisfied With My Sex Life


name: FACT-G Version 4 - I Am Forced to Spend Time in Bed


name: FACT-G Version 4 - I Am Able to Enjoy Life


name: FACT-G Version 4 - Enjoy Things I Usually Do for Fun


name: FACT-G Version 4 - Content With Quality of My Life


name: FACT-G Version 4 - Bothered by Treatment Side Effect


name: FACT-B Version 4 - Worry My Condition Will Get Worse


name: FACT-B Version 4 - Worry Family Will Get Illness


name: FACT-B Version 4 - Worry About the Effect of Stress


name: FACT-B Version 4 - Trouble Meeting Needs of Family


name: FACT-B Version 4 - Self-conscious About Way I Dress


name: FACT-B Version 4 - Satisfied With How I Am Coping


name: FACT-B Version 4 - Satisfied Family Communication of Illness


name: FACT-B Version 4 - One or Both Arms Are Swollen or Tender


name: FACT-B Version 4 - My Work Is Fulfilling


name: FACT-B Version 4 - Losing Hope Against Illness


name: FACT-B Version 4 - I Have a Lack of Energy


name: FACT-B Version 4 - I Have Been Short of Breath


name: FACT-B Version 4 - I Have Accepted My Illness


name: FACT-B Version 4 - I Get Support From My Friends


name: FACT-B Version 4 - I Feel Sexually Attractive


name: FACT-B Version 4 - I Feel Close to My Partner


name: FACT-B Version 4 - I Feel Close to My Friends


name: FACT-B Version 4 - I Am Satisfied With My Sex Life


name: FACT-B Version 4 - I Am Forced to Spend Time in Bed


name: FACT-B Version 4 - I Am Bothered by Hair Loss


name: FACT-B Version 4 - I Am Bothered by Change in Weight


name: FACT-B Version 4 - I Am Able to Feel Like a Woman


name: FACT-B Version 4 - I Am Able to Enjoy Life


name: FACT-B Version 4 - Get Emotional Support From Family


name: FACT-B Version 4 - Enjoy Things I Usually Do for Fun


name: FACT-B Version 4 - Content With Quality of My Life


name: FACT-B Version 4 - Certain Parts of Body Have Pain


name: FACT-B Version 4 - Bothered by Treatment Side Effect


name: FACIT-F Version 4 Questionnaire Question


name: FACIT-F Version 4 - Worry My Condition Will Get Worse


name: FACIT-F Version 4 - Trouble Starting Things


name: FACIT-F Version 4 - Trouble Meeting Needs of Family


name: FACIT-F Version 4 - Trouble Finishing Things


name: FACIT-F Version 4 - Satisfied With How I Am Coping


name: FACIT-F Version 4 - Satisfied Family Communication of Illness


name: FACIT-F Version 4 - Need Help Doing Usual Activities


name: FACIT-F Version 4 - My Work Is Fulfilling


name: FACIT-F Version 4 - My Family Has Accepted My Illness


name: FACIT-F Version 4 - Losing Hope Against Illness


name: FACIT-F Version 4 - Limit Social Activity, I am Tired


name: FACIT-F Version 4 - I Need to Sleep During the Day


name: FACIT-F Version 4 - I Have a Lack of Energy


name: FACIT-F Version 4 - I Have Accepted My Illness


name: FACIT-F Version 4 - I Get Support From My Friends


name: FACIT-F Version 4 - I Feel Weak All Over


name: FACIT-F Version 4 - I Feel Close to My Partner


name: FACIT-F Version 4 - I Feel Close to My Friends


name: FACIT-F Version 4 - I Am Too Tired to Eat


name: FACIT-F Version 4 - I Am Satisfied With My Sex Life


name: FACIT-F Version 4 - I Am Forced to Spend Time in Bed


name: FACIT-F Version 4 - I Am Able to Enjoy Life


name: FACIT-F Version 4 - Get Emotional Support From Family


name: FACIT-F Version 4 - Frustrated by Being Too Tired


name: FACIT-F Version 4 - Enjoy Things I Usually Do for Fun


name: FACIT-F Version 4 - Content With Quality of My Life


name: FACIT-F Version 4 - Bothered by Treatment Side Effect


name: FACIT-F Version 4 - Able to Do My Usual Activities


name: Expanded Prostate Cancer Index Composite for Clinical Practice Questionnaire


name: Expanded Disability Rating Scale - Postacute Interview Survivor Version Questionnaire


name: Expanded DRS-PI Survivor Version Questionnaire Question


name: Expanded DRS-PI Survivor Version - Work With Frequent Supervision and Support


name: Expanded DRS-PI Survivor Version - Use Toilet Independently


name: Expanded DRS-PI Survivor Version - Understand and Follow Directions


name: Expanded DRS-PI Survivor Version - Understand How to Get Dressed


name: Expanded DRS-PI Survivor Version - Successful With Limited Choices


name: Expanded DRS-PI Survivor Version - Successful With Accommodations


name: Expanded DRS-PI Survivor Version - Start and Finish Grooming Activities


name: Expanded DRS-PI Survivor Version - Require Special Aids or Equipment


name: Expanded DRS-PI Survivor Version - Require Physical Assistance


name: Expanded DRS-PI Survivor Version - Require Assistance Thinking Tasks


name: Expanded DRS-PI Survivor Version - Require Assistance Managing Emotions


name: Expanded DRS-PI Survivor Version - Perform Jobs or Manage a Home Independently


name: Expanded DRS-PI Survivor Version - Need a Helper Always Close By


name: Expanded DRS-PI Survivor Version - Need Help With All Major Activities


name: Expanded DRS-PI Survivor Version - Need 24-Hour Care


name: Expanded DRS-PI Survivor Version - Manage Clothing When Toileting


name: Expanded DRS-PI Survivor Version - Know When to Use Toilet


name: Expanded DRS-PI Survivor Version - Know Meal Times


name: Expanded DRS-PI Survivor Version - Know How to Bathe and Wash


name: Expanded DRS-PI Survivor Version - Keep Track of Time


name: Expanded DRS-PI Survivor Version - Give Correct Date and Time When Asked


name: Expanded DRS-PI Survivor Version - Function With Independent Work or Social Situations


name: Expanded DRS-PI Survivor Version - Function Completely Independently


name: Expanded DRS-PI Survivor Version - Feed Yourself Independently Without Help


name: Expanded DRS-PI Survivor Version - Can Dress and Groom Self Independently


name: Expanded DRS-PI Caregiver Version Questionnaire Question


name: Expanded DRS-PI Caregiver Version - Work With Frequent Supervision and Support


name: Expanded DRS-PI Caregiver Version - Use Toilet Independently


name: Expanded DRS-PI Caregiver Version - Use Few Words or Random Shouting


name: Expanded DRS-PI Caregiver Version - Understand and Follow Directions


name: Expanded DRS-PI Caregiver Version - Understand How to Get Dressed


name: Expanded DRS-PI Caregiver Version - Understand Feeding Utensils


name: Expanded DRS-PI Caregiver Version - Successful With Limited Choices


name: Expanded DRS-PI Caregiver Version - Successful With Accommodations


name: Expanded DRS-PI Caregiver Version - Start and Finish Grooming Activities


name: Expanded DRS-PI Caregiver Version - Require Special Aids or Equipment


name: Expanded DRS-PI Caregiver Version - Require Physical Assistance


name: Expanded DRS-PI Caregiver Version - Require Assistance Thinking Tasks


name: Expanded DRS-PI Caregiver Version - Require Assistance Managing Emotions


name: Expanded DRS-PI Caregiver Version - Perform Jobs or Manage a Home Independently


name: Expanded DRS-PI Caregiver Version - Need a Helper Always Close By


name: Expanded DRS-PI Caregiver Version - Need Help With All Major Activities


name: Expanded DRS-PI Caregiver Version - Need 24-Hour Care


name: Expanded DRS-PI Caregiver Version - Manage Clothing When Toileting


name: Expanded DRS-PI Caregiver Version - Make Sounds Not Understandable


name: Expanded DRS-PI Caregiver Version - Know When to Use Toilet


name: Expanded DRS-PI Caregiver Version - Know Meal Times


name: Expanded DRS-PI Caregiver Version - Know How to Bathe and Wash


name: Expanded DRS-PI Caregiver Version - Keep Track of Time


name: Expanded DRS-PI Caregiver Version - How They Communicate Primarily


name: Expanded DRS-PI Caregiver Version - Give Correct Date and Time When Asked


name: Expanded DRS-PI Caregiver Version - Function With Independent Work or Social Situations


name: Expanded DRS-PI Caregiver Version - Function Completely Independently


name: Expanded DRS-PI Caregiver Version - Feed Independently Without Help


name: Expanded DRS-PI Caregiver Version - Can Dress and Groom Self Independently


name: Expanded DRS-PI Caregiver Version - Able to Communicate Clearly


name: Ever Worked in Place Where Other People Smoked Cigarettes Indoors Question


name: Ever Lived in Place Where Other People Smoked Cigarettes Indoors Question


name: Ethylene-vinyl Alcohol Copolymer-based Embolic Agent


name: Establish Processes and Procedures to Verify REMS Safe Use Conditions


name: Esophageal Retention with Retrograde Flow Through Pharyngoesophageal Segment Following Swallowing


name: Esophageal Retention with Retrograde Flow Below Pharyngoesophageal Segment Following Swallowing


name: Esophageal Retention Following Swallowing


name: Escape to Nostril with or without Emission During Swallowing


name: Escape to Nasal Cavity During Swallowing


name: Escape to Lateral Buccal Cavity/Floor of Mouth


name: Escape From Interlabial Space or Lateral Juncture; No Extension


name: Embarrassed to Show Body Because of Illness Question


name: EPIC-CP - Weak Urine Stream or Incomplete Bladder Emptying


name: EPIC-CP - Vitality/Hormonal Symptom Score


name: EPIC-CP - Urinary Irritation/Obstruction Symptom Score


name: EPIC-CP - Urinary Incontinence Symptom Score


name: EPIC-CP - Rectal Pain or Urgency of Bowel Movements


name: EPIC-CP - Problem Urinary Dripping/Leakage


name: EPIC-CP - Problem Lack of Sexual Function


name: EPIC-CP - Pain or Burning With Urination


name: EPIC-CP - Overall Problems With Bowel Habits


name: EPIC-CP - Overall Problem Urinary Function


name: EPIC-CP - Hot Flashes or Breast Tenderness


name: EPIC-CP - Best Describes Urinary Control


name: EPIC-26 - Weak Urine Stream or Incomplete Emptying


name: EPIC-26 - Urinate Frequently During the Day


name: EPIC-26 - Urgency to Have a Bowel Movement


name: EPIC-26 - Overall Problem Urinary Function


name: EPIC-26 - Overall Problem Sexual Function


name: EPIC-26 - Increased Frequency of Bowel Movements


name: EPIC-26 - How Often Have You Leaked Urine


name: EPIC-26 - Best Describes Urinary Control


name: EPIC-26 - Abdominal or Pelvic or Rectal Pain


name: EORTC Olsen Mycosis Fungoides And Sezary Syndrome 2011 Oncology Response Criteria


name: EMA Decision Number for Pediatric Investigation Plan


name: ELN Allele with Mm Haplotype for INT20/INT23


name: EBMT Blade Myeloma 1998 Oncology Response Criteria


name: Dusting or Polishing Furniture or a Polishing Car Question


name: Durie Multiple Myeloma 2006 Oncology Response Criteria


name: Dressing or Undressing Without Rest or a Break Question


name: Dressing or Undressing Without Assistance Question


name: Double-Walled Airbag Breast Immobilization Device


name: Don't Know or Not Sure When Smoked a Cigarette


name: Doing Calisthenics or Aerobic Dancing 5 Minutes Nonstop Question


name: Dohner AML 2010 Oncology Response Criteria


name: Do Not Distribute, Transfer, Loan, or Sell Product


name: Dizzy When Standing Up from a Sitting or Lying Position Question


name: Disorganized Chewing or Mashing with Solid Pieces of Bolus Unchewed


name: Difficulty of Reaching Orgasm with Sexual Stimulation or Intercourse Question


name: Difficulty in Maintenance of Lubrication Until Completion of Sexual Activity or Intercourse Question


name: Difficulty Finding Clothes to Fit Question


name: Difficulty Becoming Lubricated During Sexual Activity or Intercourse Question


name: Designate a Healthcare Setting Representative


name: Cubic Millimeter per Square Millimeter per Year


name: Cross-sectional Thickness at End Ventricular Systole


name: Cross-sectional Thickness at End Ventricular Diastole


name: Cross-sectional Diameter at Mid Ventricular Systole


name: Cross-sectional Diameter at End Ventricular Systole


name: Cross-sectional Diameter at End Ventricular Diastole


name: Confidence of Becoming Sexually Aroused During Sexual Activity or Intercourse Question


name: Complete Superior Movement of Thyroid Cartilage During Swallowing


name: Complete Pharyngeal Clearance Following Swallowing


name: Complete Inversion of Epiglottis During Swallowing


name: Complete Healthcare Knowledge Assessment


name: Complete Distension and Complete Duration of Pharyngoesophageal Segment Opening During Swallowing


name: Complete Anterior Movement of Hyoid During Swallowing


name: Collection of Residue Within or On Pharyngeal Structures Following Swallowing


name: Cohesive Bolus Between Tongue to Palatal Seal


name: Climbing 50 Steps or 2 1/2 Floors Question


name: Chronic Respiratory Questionnaire Self-Administered Standardized Format


name: Chollet Breast Cancer 2002 Oncology Response Criteria


name: Chimeric Antigen Receptor T-Cell Therapy


name: Cheson Non-Hodgkins Lymphoma 1999 Oncology Response Criteria


name: Cheson Non-Hodgkins Hodgkins Lymphoma 1993 Oncology Response Criteria


name: Cheson Malignant Lymphoma 2007 Oncology Response Criteria


name: Cheson Lymphoma 2008 Oncology Response Criteria


name: Cheson Hodgkins Non-Hodgkins Lymphoma 2008 Oncology Response Criteria


name: Cheson CLL 2012 Oncology Response Criteria


name: Cheson CLL 2006 Oncology Response Criteria


name: Center for Epidemiologic Studies Depression Scale Revised


name: Carrying a Light Load of Groceries Question


name: Carrying a Heavy Load of Groceries Question


name: Carbohydrate-Deficient Transferrin to Transferrin Ratio Measurement


name: Cancer Rehabilitation Evaluation System for Research


name: Cancer Patient Tobacco Use Questionnaire


name: Burcombe Breast Cancer 2005 Oncology Response Criteria


name: Bruggemann MRD 2010 Oncology Response Criteria


name: Broccoli Sprout/Broccoli Seed Extract Supplement


name: Boonsirikamchai Colorectal Cancer 2011 Oncology Response Criteria


name: Blazer Colorectal Cancer 2008 Oncology Response Criteria


name: Biospecimen Retained and/or Contains DNA Indicator


name: Bilateral Bulging on Pharyngeal Contraction


name: Beta-2 Microglobulin to Creatinine Ratio Measurement


name: Behavior Assessment System for Children, Third Edition


name: Bayer Classification of Visual Acuity Changes


name: Bayer Classification for Corneal Epitheliopathy


name: Band Form Granulocyte to Total Cell Ratio Measurement


name: Average Number Cigarettes Smoked a Day Question


name: Average Hours Per Week Spent on Activity Question


name: Autologous Tumor-associated Peptide Antigen-pulsed Dendritic Cell Vaccine


name: Attending a Movie, Play, Church Event, or Sports Activity Question


name: Assistance Used to Quit or Stay Off Smoking Cigarettes Since Diagnosis Question


name: Assistance Used to Quit or Stay Off Smoking Cigarettes Past 30 Days Question


name: Arizona Sexual Experiences Scale-Male Version Questionnaire


name: Arizona Sexual Experiences Scale-Female Version Questionnaire


name: Aortic Regurgitant Jet Width to Left Ventricular Outflow Tract Diameter Ratio


name: Adhere to REMS Patient Safe Use Conditions


name: Adequate Information Given About Physical Condition and Treatment Question


name: Adaptive Behavior Assessment System, Parent Rating Form


name: Adaptive Behavior Assessment System, Adult Rating Form


name: ASEX-Male Version Questionnaire Question


name: ASEX-Female Version Questionnaire Question


name: ASEX-Female Version - Vagina Become Moist


name: ASEX-Female Version - Orgasms Satisfying


name: decreased absolute neurophile count (ANC)


name: lesions showing histological features both of aneurysmal cyst and of another fibro-osseous lesion


name: nonteratogenic effects of substances transmitted via placenta


name: the listed conditions, without further specification, as causes of morbidity or additional care, in newborn


name: abnormal findings in prostatic secretions


name: abnormal findings in semen, seminal fluid


name: abnormal findings in secretion and smears from cervix uteri


name: abnormal findings in secretion and smears from vagina


name: abnormal findings in secretion and smears from vulva


name: nonspecific abnormal findings on diagnostic imaging by computerized axial tomography [CAT scan]


name: nonspecific abnormal findings on diagnostic imaging by magnetic resonance imaging [MRI][NMR]


name: nonspecific abnormal findings on diagnostic imaging by positron emission tomography [PET scan]


name: nonspecific abnormal findings on diagnostic imaging by thermography


name: nonspecific abnormal findings on diagnostic imaging by ultrasound [echogram]


name: nonspecific abnormal findings on diagnostic imaging by X-ray examination


name: abnormal results of radionuclide [radioisotope] uptake studies


name: Undetermined intent is only for use when there is specific documentation in the record that the intent of the injury cannot be determined. If no such documentation is present, code to accidental (unintentional)


name: encounter for examination for medicolegal reasons


name: Categories Z40-Z53 are intended for use to indicate a reason for care. They may be used for patients who have already been treated for a disease or injury, but who are receiving aftercare or prophylactic care, or care to consolidate the treatment, or to deal with a residual state


name: passage of sounds or bougies through artificial openings


name: removal of catheter from artificial openings


name: toilet or cleansing of artificial openings


name: removal or replacement of external prosthetic device


name: removal or replacement of implanted device


name: current and past negative life events in childhood


name: current and past problems of a child related to upbringing


name: counseling for victims and perpetrators of abuse


name: contact with and (suspected) exposures to potential hazards to health


name: long term (current) drug use for prophylactic purposes


name: postprocedural or post-traumatic loss of body part NEC


name: organ or tissue replaced by heterogenous or homogenous transplant


name: Medical Food Oral Powder for Suspension [Glytactin Build 10PE]


name: Sure Comfort 3/10ML 31G 5/16 inch Short Needle Insulin Syringe


name: Sure Comfort 3/10ML 31G 5/16 inch Insulin Syringe


name: Sure Comfort 3/10ML 31G 1/4 inch Short Needle Insulin Syringe


name: Sure Comfort 3/10ML 30G 5/16 inch Short Needle Insulin Syringe


name: Sure Comfort 3/10ML 30G 1/2 inch Insulin Syringe


name: Sure Comfort 3/10ML 29G 1/2 inch Insulin Syringe


name: Sure Comfort 1ML 31G 5/16 inch Short Needle Syringe


name: Sure Comfort 1ML 31G 1/4 inch Short Needle Insulin Syringe


name: Sure Comfort 1ML 30G 1/2 inch Insulin Syringe


name: Sure Comfort 1ML 29G 1/2 inch Insulin Syringe


name: Sure Comfort 1ML 28G 1/2 inch Insulin Syringe


name: Sure Comfort 1/2ML 31G 5/16 inch Short Needle Insulin Syringe


name: Sure Comfort 1/2ML 31G 1/4 inch Short Needle Insulin Syringe


name: Sure Comfort 1/2ML 30G 5/16 inch Short Needle Insulin Syringe


name: Sure Comfort 1/2ML 30G 1/2 inch Insulin Syringe


name: Sure Comfort 1/2ML 29G 1/2 inch Insulin Syringe


name: Sure Comfort 1/2ML 28G 1/2 inch Insulin Syringe


name: Nutricia Neocate Syneo Infant Prebiotics + Probiotics Powder


name: Pediatric Electrolyte Solution with Zinc (Fruit)


name: Nature's Blend Gelatin Capsules, 10 grain


name: Medical Food Oral Powder for Suspension [Tylactin Restore 5PE]


name: Medical Food Oral Powder for Suspension [Glytactin Restore Lite 10PE]


name: Bupivacaine Hydrochloride;Isopropyl Alcohol;Lidocaine Hydrochloride;Methylprednisolone Acetate;Povidone Iodine;Sodium Chloride 0.25%; 70%; 1%; 80 MG/1 ML; 10%; 0.9% Multiple Routes Kit [Active Injection Kit LM-Dep-1]


name: gatifloxacin 100 % MISCELL POWDER (GRAM)


name: Capsaicin/Menthol;Celecoxib 0.0375%-5%; 200 MG Multiple Routes Kit


name: OCTINOXATE 70 mg in 1 g / OXYBENZONE 50 mg in 1 g TOPICAL LIPSTICK [Lip Clear Lysine Plus Coldstick]


name: Carmex Daily Care Moisturizing Lip Balm SPF 15 KIT


name: OCTINOXATE 75 mg in 1 g / OXYBENZONE 40 mg in 1 g TOPICAL SALVE [Crisp Apple Cider]


name: OCTINOXATE 7.5 g in 100 g / OXYBENZONE 4 g in 100 g TOPICAL SALVE [Carmex Daily Care Moisturizing Lip Balm Honey Dew Melon SPF 15]


name: Cyanocobalamin 1000 MCG/1 ML Injection Solution [Vitamin Deficiency Injectable System - B12]


name: Chlorhexidine Gluconate/Isopropyl Alcohol;Lidocaine Hydrochloride 2%-70%; 4% Multiple Routes Solution [VacuStim Silver]


name: STYPHNOLOBIUM JAPONICUM FLOWER BUD 0.10 g in 300 mL TOPICAL SHAMPOO [BARAMO for Normal Scalp]


name: STYPHNOLOBIUM JAPONICUM FLOWER BUD 0.03 g in 70 mL TOPICAL SOLUTION [BARAMO Scalp Serum for Normal Scalp]


name: POTASSIUM BROMIDE 1 g in 1 g NOT APPLICABLE POWDER


name: Glycerin 2.18 g in 27 g / Adenosine 0.01 g in 27 g TOPICAL PATCH [TAMHADA Synergy Anti Wrinkle Face And Neck Mask]


name: Glycerin 1.85 g in 23 g / Niacinamide 0.46 g in 23 g TOPICAL PATCH [TAMHADA Synergy Whitening Mask]


name: Glycerin 1.84 g in 23 g TOPICAL PATCH [TAMHADA Synergy Moisturizing Mask]


name: OCTINOXATE 0.075 g in 1 g / TITANIUM DIOXIDE 0.042 g in 1 g / ZINC OXIDE 0.07 g in 1 g TOPICAL CREAM [MISSHA M Perfect Cover BB SPF42 No29]


name: ALUMINUM CHLOROHYDRATE 20 g in 100 g TOPICAL STICK [Dove Fresh 24h Invisible Solid Antiperspirant Deodorant]


name: ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY 11.4 g in 100 g TOPICAL STICK [Axe Signature Night Antiperspirant]


name: PANTHENOL 1.5 g in 300 mL / MENTHOL 1.5 g in 300 mL TOPICAL SHAMPOO [EH Plus H2CO3 Cool SB]


name: PANTHENOL 1.5 g in 300 mL / MENTHOL 1.5 g in 300 mL TOPICAL SHAMPOO [EH Plus H2CO3 Cool CA]


name: Titanium Dioxide 0.01 g in 3.5 g TOPICAL LIPSTICK [3CE LIP COLOR 905 GONE BAD]


name: {24 (drospirenone 3 MG / ethinyl estradiol 0.02 MG / levomefolate calcium 0.451 MG Oral Tablet) / 4 (levomefolate calcium 0.451 MG Oral Tablet) } Pack [Rajani 28 Day]


name: TITANIUM DIOXIDE 1.4592 g in 12 g / OCTINOXATE 0.84 g in 12 g / OCTISALATE 0.36 g in 12 g TOPICAL CREAM [SNP Animal Tiger Long-lasting Cover Cushion]


name: TITANIUM DIOXIDE 1.0752 g in 12 g / OCTINOXATE 0.84 g in 12 g / OCTISALATE 0.36 g in 12 g TOPICAL CREAM [SNP Animal Panda Luminous Cover Cushion]


name: Allantoin 0.006 g in 6.6 g TOPICAL LIQUID [3CE FIXER AND MASCARA BLACK]


name: {28 (norethindrone 0.35 MG Oral Tablet) } Pack [Incassia 28 Day]


name: octinoxate 60 mg in 1 g / octisalate 50 mg in 1 g / oxybenzone 40 mg in 1 g / titanium dioxide 39 mg in 1 g / zinc oxide 20 mg in 1 g TOPICAL LOTION [Age Renewal Firming]


name: homosalate 100 mg in 1 mL / octisalate 50 mg in 1 mL / avobenzone 20 mg in 1 mL / octocrylene 15 mg in 1 mL / oxybenzone 40 mg in 1 mL TOPICAL LIQUID [SkinPharmacy Advanced Anti-Aging Therapy Retinol Day Moisturizer SPF 30]


name: homosalate 100 g in 2 mL / octisalate 50 g in 2 mL / avobenzone 30 g in 2 mL / octocrylene 20 g in 2 mL / oxybenzone 50 g in 2 mL TOPICAL LOTION [SkinPharmacy Advanced Anti-Aging Therapy Glycolic Day Moisturizer SPF 30]


name: Titanium Dioxide 1.74 g in 12 g / Octinoxate 0.80 g in 12 g / Octisalate 0.48 g in 12 g TOPICAL POWDER [3CE Fitting Cushion Foundation 002]


name: Titanium Dioxide 1.69 g in 12 g / Octinoxate 0.80 g in 12 g / Octisalate 0.48 g in 12 g TOPICAL POWDER [3CE Fitting Cushion Foundation 001]


name: Titanium Dioxide 1.06 g in 12 g / Octinoxate 0.80 g in 12 g / Octisalate 0.48 g in 12 g TOPICAL POWDER [3CE Tinted moisture cushion CC 001]


name: Titanium Dioxide 1.04 g in 12 g / Octinoxate 0.80 g in 12 g / Octisalate 0.48 g in 12 g TOPICAL POWDER [3CE Tinted moisture cushion CC 002]


name: Skin Pharmacy Advanced Acne Therapy Kit KIT


name: ROBENIDINE HYDROCHLORIDE 30 g in 0.45 kg ORAL POWDER [Robenz]


name: ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY 11.4 g in 100 g TOPICAL STICK [Degree Men Motionsense UltraClear Black and White 48H Antiperspirant]


name: Titanium Dioxide 0.18 g in 4.5 g TOPICAL LIPSTICK [3CE CRE AMY LIP COLOR 08 LADI DADI]


name: Titanium Dioxide 0.03 g in 4.5 g TOPICAL LIPSTICK [3CE CRE AMY LIP COLOR 09 KI TSCH BIKER]


name: Titanium Dioxide 0.22 g in 4.5 g TOPICAL LIPSTICK [3CE CRE AMY LIP COLOR 10 ROLLER COASTER]


name: Titanium Dioxide 0.17 g in 4.5 g TOPICAL LIPSTICK [3CE CRE AMY LIP COLOR 06 JAZZY PINK]


name: Titanium Dioxide 0.16 g in 4.5 g TOPICAL LIPSTICK [3CE CRE AMY LIP COLOR 05 DAZZLING]


name: Titanium Dioxide 0.15 g in 4.5 g TOPICAL LIPSTICK [3CE CRE AMY LIP COLOR 04 JOYCE]


name: Titanium Dioxide 0.13 g in 4.5 g TOPICAL LIPSTICK [3CE CRE AMY LIP COLOR 12 ME ME]


name: Titanium Dioxide 0.11 g in 4.5 g TOPICAL LIPSTICK [3CE CRE AMY LIP COLOR 03 ZOOM IN]


name: Titanium Dioxide 0.09 g in 4.5 g TOPICAL LIPSTICK [3CE CRE AMY LIP COLOR 16 GIDDY UP]


name: Lanolin 0.02 g in 1.1 g TOPICAL LIPSTICK [3CE DRAWING LIP CHILLING]


name: Titanium Dioxide 0.04 g in 1.1 g TOPICAL LIPSTICK [3CE DRAWING LIP SLOE GIN]


name: Titanium Dioxide 0.02 g in 4.5 g TOPICAL LIPSTICK [3CE CRE AMY LIP COLOR 01 PICK ME UP]


name: Titanium Dioxide 0.65 g in 5 mL TOPICAL LIQUID [3CE FULL COVER CONCEALER 001]


name: Titanium Dioxide 0.26 g in 1.1 g TOPICAL LIPSTICK [3CE DRAWING LIP PEN BUTTER PINK]


name: Titanium Dioxide 0.23 g in 1.1 g TOPICAL LIPSTICK [3CE DRAWING LIP PEN ENDEAR]


name: Titanium Dioxide 0.22 g in 1.1 g TOPICAL LIPSTICK [3CE DRAWING LIP PEN LITTLE MORE]


name: Titanium Dioxide 0.19 g in 6 g TOPICAL LIQUID [3CE EYEBROW MASCARA GOLD BROWN]


name: Titanium Dioxide 0.16 g in 6 g TOPICAL LIQUID [3CE EYEBROW MASCARA BLONDIE GOLD]


name: Titanium Dioxide 0.08 g in 1.1 g TOPICAL LIPSTICK [3CE DRAWING LIP PEN BEWARE]


name: Titanium Dioxide 0.06 g in 6 g TOPICAL LIQUID [3CE EYEBROW MASCARA BROWN]


name: Titanium Dioxide 0.01 g in 1.1 g TOPICAL LIPSTICK [3CE DRAWING LIP PEN BORN RED]


name: OCTINOXATE 70 mg in 1 g / OXYBENZONE 50 mg in 1 g TOPICAL LIPSTICK [Super Lysine Plus Coldstick]


name: Dimethicone 0.006 g in 1 g TOPICAL LIPSTICK [3CE MATTE LIP CRAYON DUBIOUS]


name: Glycerin 1.50 g in 50 g TOPICAL PATCH [Rubelli Wine Hand Packs]


name: Glycerin 1.50 g in 50 g TOPICAL PATCH [Rubelli Wine Foot Packs]


name: SELAMECTIN 1 kg in 1 kg NOT APPLICABLE POWDER


name: ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLY 12.8 g in 64 g TOPICAL STICK [Vanicream Anti-perspirant/Deodorant]


name: ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY 20 g in 100 g TOPICAL STICK [Suave Clinical Protection Sweet Pea and Violet Anti-Perspirant]


name: PADIMATE O 7 g in 100 g / TITANIUM DIOXIDE 17.45 g in 100 g TOPICAL STICK [Translucent Broad Spectrum Foundation SPF 50 Vertra]


name: Titanium Dioxide 0.20 g in 3.5 g TOPICAL LIPSTICK [3CE LIP COLOR 706 SWEET IMPACT]


name: Titanium Dioxide 0.129 g in 1 g TOPICAL LIPSTICK [3CE MATTE LIP CRAYON HEAVEN WAY]


name: Titanium Dioxide 0.11 g in 1 g TOPICAL LIPSTICK [3CE MATTE LIP CRAYON BLUSHED]


name: Titanium Dioxide 0.107 g in 1 g TOPICAL LIPSTICK [3CE MATTE LIP CRAYON PINK LEAVES]


name: Titanium Dioxide 0.10 g in 3.5 g TOPICAL LIPSTICK [3CE LIP COLOR 704 CURTAIN CALL]


name: Titanium Dioxide 0.097 g in 1 g TOPICAL LIPSTICK [3CE MATTE LIP CRAYON PEEKABOO]


name: Titanium Dioxide 0.081 g in 1 g TOPICAL LIPSTICK [3CE MATTE LIP CRAYON TERRIFIC]


name: Titanium Dioxide 0.03 g in 1 g TOPICAL LIPSTICK [3CE MATTE LIP CRAYON HOTLINE]


name: Titanium Dioxide 0.005 g in 1 g TOPICAL LIPSTICK [3CE MATTE LIP CRAYON AIRY RED]


name: GLYCERIN 0.175 mg in 5 mL TOPICAL CREAM [myCellCare]


name: Titanium Dioxide 0.17 g in 3.5 g TOPICAL LIPSTICK [3CE LIP COLOR 402 FUCHSIA]


name: Titanium Dioxide 0.15 g in 3.5 g TOPICAL LIPSTICK [3CE LIP COLOR 507 LALA]


name: Titanium Dioxide 0.12 g in 3.5 g TOPICAL LIPSTICK [3CE LIP COLOR 506 DAILY LADY]


name: Titanium Dioxide 0.10 g in 3.5 g TOPICAL LIPSTICK [3CE LIP COLOR 602 V]


name: Titanium Dioxide 0.07 g in 3.5 g TOPICAL LIPSTICK [3CE LIP COLOR 501 BELLA]


name: Titanium Dioxide 0.04 g in 3.5 g TOPICAL LIPSTICK [3CE LIP COLOR 409 KISS WOO]


name: Titanium Dioxide 0.02 g in 3.5 g TOPICAL LIPSTICK [3CE LIP COLOR 503 GLASS HOT PINK]


name: Titanium Dioxide 0.01 g in 3.5 g TOPICAL LIPSTICK [3CE LIP COLOR 609 JAMMER]


name: Epinephrine;Isopropyl Alcohol 1 MG/1 ML; 70% Multiple Routes Kit [Adyphren]


name: Epinephrine;Isopropyl Alcohol 1 MG/1 ML; 70% Multiple Routes Kit [Adyphren II]


name: ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY 11.4 g in 100 g TOPICAL STICK [Dove]


name: {21 (ethinyl estradiol 0.03 MG / levonorgestrel 0.15 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Ayuna 28 Day Pack]


name: Allantoin 0.04 g in 5 g TOPICAL SOLUTION [HYUNDAE MEDITECH BIO HAIR SOLU TION ERUA DO]


name: Titanium Dioxide 0.12 g in 3.5 g TOPICAL LIPSTICK [3CE LIP COLOR 308 PINK JAM]


name: Titanium Dioxide 0.05 g in 3.5 g TOPICAL LIPSTICK [3CE LIP COLOR 401 SCANDAL]


name: Titanium Dioxide 0.02 g in 3.5 g TOPICAL LIPSTICK [3CE LIP COLOR 204 COME TO ME]


name: ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY 20 g in 100 g TOPICAL STICK [Suave Clinical Protection Lavender Fresh Anti-Perspirant]


name: CYCLOMETHICONE 5 0.17 g in 8.5 g TOPICAL LIQUID [3CE PINK IM GOOD MASCARA]


name: Titanium Dioxide 0.68 g in 8 g TOPICAL POWDER [3CE EYE SHADOW PALETTE SADDLE]


name: Titanium Dioxide 0.67 g in 8 g TOPICAL POWDER [3CE EYE SHADOW PALETTE BITTER SWEET]


name: Titanium Dioxide 0.52 g in 8 g TOPICAL POWDER [3CE EYE SHADOW PALETTE UP CLOSE]


name: Titanium Dioxide 0.47 g in 8 g TOPICAL POWDER [3CE EYE SHADOW PALETTE SIENNA]


name: Titanium Dioxide 0.37 g in 5 g TOPICAL POWDER [3CE DUO COLOR FACE BLUSH PEACH CRUSH]


name: Titanium Dioxide 0.31 g in 5 g TOPICAL POWDER [3CE DUO COLOR FACE BLUSH MISS FLOWER]


name: Titanium Dioxide 0.28 g in 5 g TOPICAL POWDER [3CE DUO COLOR FACE BLUSH CREME DE VIOLETTE]


name: Titanium Dioxide 0.15 g in 3.5 g TOPICAL LIPSTICK [3CE LIP COLOR 804 STAY BY ME]


name: Titanium Dioxide 0.12 g in 5 g TOPICAL POWDER [3CE DUO COLOR FACE BLUSH RETRO DRIVE]


name: Titanium Dioxide 0.10 g in 3.5 g TOPICAL LIPSTICK [3CE LIP COLOR 805 R 19]


name: Titanium Dioxide 0.10 g in 3.5 g TOPICAL LIPSTICK [3CE LIP COLOR 803 CLASSIC ROSY]


name: Titanium Dioxide 0.07 g in 5 g TOPICAL POWDER [3CE DUO COLOR FACE BLUSH MAKE ME BLUSH]


name: ZINC OXIDE 216 mg in 1 mL TOPICAL LOTION [Neutrogena pure and free baby SUNSCREEN Broad Spectrum SPF 50]


name: ZINC OXIDE 216 mg in 1 mL TOPICAL LOTION [Neutrogena Sheer Zinc DRY-TOUCH Sunscreen Broad Spectrum SPF50]


name: ZINC OXIDE 216 mg in 1 mL TOPICAL LOTION [Aveeno Baby continuous protection sensitive skin Sunscreen Broad Spectrum SPF50]


name: Glycerin 0.19 g in 6.5 g TOPICAL LIQUID [3CE LIQU ID EYE LINER BLACK]


name: Triethylhexanoin 0.31 g in 3.5 g TOPICAL LIPSTICK [3CE LIP COLOR 906 BITE IT]


name: Isopropyl Alcohol;Lidocaine Hydrochloride 70%; 2% Multiple Routes Kit [Venipuncture PX1]


name: Titanium Dioxide 0.29 g in 3.5 g TOPICAL LIPSTICK [3CE LIP COLOR 806 DUSTY CORAL]


name: Titanium Dioxide 0.14 g in 3.5 g TOPICAL LIPSTICK [3CE LIP COLOR 807 HYPNOTIC]


name: Titanium Dioxide 0.13 g in 3.5 g TOPICAL LIPSTICK [3CE LIP COLOR 902 ROSE BREATH]


name: Titanium Dioxide 0.13 g in 3.5 g TOPICAL LIPSTICK [3CE LIP COLOR 309 CELEBRITY]


name: Titanium Dioxide 0.014 g in 3.5 g TOPICAL LIPSTICK [3CE LIP COLOR 903 GLASS ROSY]


name: Titanium Dioxide 0.010 g in 3.5 g TOPICAL LIPSTICK [3CE LIP COLOR 904 GLASS BERRY]


name: {28 (norethindrone 0.35 MG Oral Tablet) } Pack [Norlyda 28 Day]


name: OCTINOXATE 2.01 mg in 30 mL / TITANIUM DIOXIDE 1.06 mg in 30 mL / OCTISALATE 0.075 mg in 30 mL TOPICAL CREAM [KLAVUU WHITE PEARLSATION Ideal Actress Backstage Cream SPF30]


name: AVOBENZONE 1.5 g in 50 g / OCTOCRYLENE 3.75 g in 50 g / OCTISALATE 2.5 g in 50 g TOPICAL CREAM [No7 Protect and Perfect Intense Advanced Day Cream SPF 30]


name: CEFTIOFUR SODIUM 495 g in 500 g NOT APPLICABLE POWDER [X]


name: OCTINOXATE 3.5 g in 50 mL / OCTISALATE 2.5 g in 50 mL / OCTOCRYLENE 1.5 g in 50 mL / TITANIUM DIOXIDE 1 g in 50 mL TOPICAL CREAM [Pollen UV Perfect Daily Sunscreen]


name: Avobenzone 26.8 mg in 1 g / Homosalate 96 mg in 1 g / Octisalate 28.8 mg in 1 g / Octocrylene 53.8 mg in 1 g / Oxybenzone 34.6 mg in 1 g TOPICAL SPRAY [La Roche Posay Laboratoire Dermatologique Anthelios 60 Ultra Light Sunscreen Broad Spectrum SPF 60 Water Resistant 80 Minutes]


name: Titanium Dioxide 0.23 g in 3.5 g TOPICAL POWDER [3CE TRIPLE SHADOW NO NONO]


name: prenatal vit no.100/iron ps cplex,sod EDTA/folic acid/omega3 27 mg iron-1 mg-374 mg ORAL COMBINATION PACKAGE, TABLET AND DR CAP


name: methylprednisolone acetate/norflurane/HFC 245fa 40 mg/mL MISCELL KIT


name: methylprednisolone acetate/norflurane/HFC 245fa 40 mg/mL (2 x 1 mL) MISCELL KIT


name: clotrimazole/betamethasone dipropionate/zinc oxide 1 %-0.05 %-20 % TOPICAL COMBINATION PACKAGE (GRAM)


name: bupivacaine HCl/PF/norflurane/pentafluoropropane (HFC 245fa) 5 mg/mL MISCELL KIT


name: suppository base no.216 MISCELL WAX (GRAM)


name: nutritional therapy for phenylketonuria (PKU), no.63 25 gram-363 kcal/100 gram ORAL POWDER IN PACKET (EA)


name: kit for the preparation of Ga-68/dotatate 40 mcg INTRAVEN VIAL (EA)


name: fructooligosaccharides/polydextrose 12 gram/30 mL ORAL LIQUID IN PACKET (ML)


name: diethyltoluamide 5 % TOPICAL SPRAY, NON-AEROSOL (ML)


name: cholera vaccine buffer component ORAL SUSPENSION, RECONSTITUTED, ORAL (ML)


name: diclofenac sodium/capsaicin 1.5 %-0.025 % TOPICAL KIT, CREAM AND SOLUTION


name: nut.therapy, phenylketonuria (PKU), no.63


name: GLUCOCARD 01 SENSOR PLUS (GLUCOSE) TEST STRIP


name: GLUCOCARD VITAL SENSOR (GLUCOSE) TEST STRIP


name: cat dander allergenic extract / cat skin extract


name: SET,INFUSION 19GA 3/4IN SMITHS#21-3368-24


name: CATHERIZATION SET,INTERMITTENT 12FR C#28522-FEMALE


name: IRRIGATING SYRINGE,PISTON ENFIT TIP 60ML


name: CATHETER,INTERMITTENT 10FR FEMALE COLOPLAST #28510


name: CATHETER,INTERMITTENT,MAGIC3 14FR ROCHESTER #53614G


name: DRESSING CUTIMED SORBACT SWAB BSN #7216800


name: TRACH STOMA PROTECTOR,FOAM 2.75IN X 2.75IN LUMINAUD #63026


name: WINGS CONTOURED INCONTINENT BRIEF XX-LARGE


name: FEEDING BAG W/GRAVITY SET ENFIT COVIDIEN #702520


name: implied consent with opportunity to dissent


name: Guidelines for Current Procedural Terminology Concepts


name: Results, Testing, Interpretation, and Report


name: Separate or Multiple Procedures (Anesthesia)


name: Follow-Up Care for Diagnostic Surgical Procedures


name: Follow-Up Care for Therapeutic Surgical Procedures


name: Reporting More Than One Procedure/Service (Surgery)


name: Insertion of interlaminar/interspinous process stabilization/distraction device, without fusion, including image guidance when performed, with open decompression, lumbar


name: Insertion of interlaminar/interspinous process stabilization/distraction device, without open decompression or fusion, including image guidance when performed, lumbar


name: Closed treatment of posterior pelvic ring fracture(s), dislocation(s), diastasis or subluxation of the ilium, sacroiliac joint, and/or sacrum, with or without anterior pelvic ring fracture(s) and/or dislocation(s) of the pubic symphysis and/or superior/inferior rami, unilateral or bilateral


name: Hallux rigidus correction with cheilectomy, debridement and capsular release of the first metatarsophalangeal joint; without implant


name: Hallux rigidus correction with cheilectomy, debridement and capsular release of the first metatarsophalangeal joint; with implant


name: Correction, hallux valgus with bunionectomy, with sesamoidectomy when performed


name: Laryngoscopy, flexible; with ablation or destruction of lesion(s) with laser, unilateral


name: Laryngoscopy, flexible; with therapeutic injection(s) (eg, chemodenervation agent or corticosteroid, injected percutaneous, transoral, or via endoscope channel), unilateral


name: Laryngoscopy, flexible; with injection(s) for augmentation (eg, percutaneous, transoral), unilateral


name: Laryngoscopy, flexible; with removal of foreign body(s)


name: Laryngoscopy, flexible; with removal of lesion(s), non-laser


name: Laryngoscopy, flexible or rigid telescopic, with stroboscopy


name: Laryngoplasty; with open reduction and fixation of (eg, plating) fracture, includes tracheostomy, if performed


name: Percutaneous transcatheter closure of the left atrial appendage with endocardial implant, including fluoroscopy, transseptal puncture, catheter placement(s), left atrial angiography, left atrial appendage angiography, when performed, and radiological supervision and interpretation


name: Replacement, aortic valve, open, with cardiopulmonary bypass


name: Partial exchange transfusion, blood, plasma or crystalloid necessitating the skill of a physician or other qualified health care professional, newborn


name: Endovenous ablation therapy of incompetent vein, extremity, inclusive of all imaging guidance and monitoring, percutaneous, mechanochemical


name: Endovenous ablation therapy of incompetent vein, extremity, inclusive of all imaging guidance and monitoring, percutaneous, mechanochemical; first vein treated


name: Endovenous ablation therapy of incompetent vein, extremity, inclusive of all imaging guidance and monitoring, percutaneous, mechanochemical; subsequent vein(s) treated in a single extremity, each through separate access sites (List separately in addition to code for primary procedure)


name: Transluminal balloon angioplasty, central dialysis segment, performed through dialysis circuit, including all imaging and radiological supervision and interpretation required to perform the angioplasty (List separately in addition to code for primary procedure)


name: Transcatheter placement of intravascular stent(s), central dialysis segment, performed through dialysis circuit, including all imaging and radiological supervision and interpretation required to perform the stenting, and all angioplasty in the central dialysis segment (List separately in addition to code for primary procedure)


name: Dialysis circuit permanent vascular embolization or occlusion (including main circuit or any accessory veins), endovascular, including all imaging and radiological supervision and interpretation necessary to complete the intervention (List separately in addition to code for primary procedure)


name: Transluminal balloon angioplasty (except lower extremity artery(ies) for occlusive disease, intracranial, coronary, pulmonary, or dialysis circuit), open or percutaneous, including all imaging and radiological supervision and interpretation necessary to perform the angioplasty within the same artery


name: Transluminal balloon angioplasty (except lower extremity artery(ies) for occlusive disease, intracranial, coronary, pulmonary, or dialysis circuit), open or percutaneous, including all imaging and radiological supervision and interpretation necessary to perform the angioplasty within the same artery; initial artery


name: Transluminal balloon angioplasty (except lower extremity artery(ies) for occlusive disease, intracranial, coronary, pulmonary, or dialysis circuit), open or percutaneous, including all imaging and radiological supervision and interpretation necessary to perform the angioplasty within the same artery; each additional artery (List separately in addition to code for primary procedure)


name: Transluminal balloon angioplasty (except dialysis circuit), open or percutaneous, including all imaging and radiological supervision and interpretation necessary to perform the angioplasty within the same vein


name: Transluminal balloon angioplasty (except dialysis circuit), open or percutaneous, including all imaging and radiological supervision and interpretation necessary to perform the angioplasty within the same vein; initial vein


name: Transluminal balloon angioplasty (except dialysis circuit), open or percutaneous, including all imaging and radiological supervision and interpretation necessary to perform the angioplasty within the same vein; each additional vein (List separately in addition to code for primary procedure)


name: Laparoscopy, surgical, esophageal sphincter augmentation procedure, placement of sphincter augmentation device (ie, magnetic band), including cruroplasty when performed


name: Removal of esophageal sphincter augmentation device


name: Placement of stent(s) into a bile duct, percutaneous, including diagnostic cholangiography, imaging guidance (eg, fluoroscopy and/or ultrasound), balloon dilation, catheter exchange(s) and catheter removal(s) when performed, and all associated radiological supervision and interpretation


name: Laparoscopy, surgical, ablation of uterine fibroid(s) including intraoperative ultrasound guidance and monitoring, radiofrequency


name: Injection(s), of diagnostic or therapeutic substance(s) (eg, anesthetic, antispasmodic, opioid, steroid, other solution), not including neurolytic substances, including needle or catheter placement, interlaminar epidural or subarachnoid, cervical or thoracic


name: Injection(s), of diagnostic or therapeutic substance(s) (eg, anesthetic, antispasmodic, opioid, steroid, other solution), not including neurolytic substances, including needle or catheter placement, interlaminar epidural or subarachnoid, lumbar or sacral (caudal)


name: Injection(s), including indwelling catheter placement, continuous infusion or intermittent bolus, of diagnostic or therapeutic substance(s) (eg, anesthetic, antispasmodic, opioid, steroid, other solution), not including neurolytic substances, interlaminar epidural or subarachnoid, cervical or thoracic


name: Injection(s), including indwelling catheter placement, continuous infusion or intermittent bolus, of diagnostic or therapeutic substance(s) (eg, anesthetic, antispasmodic, opioid, steroid, other solution), not including neurolytic substances, interlaminar epidural or subarachnoid, lumbar or sacral (caudal)


name: Endoscopic Decompression of Neural Elements and/or Excision of Herniated Intervertebral Discs


name: Endoscopic decompression of spinal cord, nerve root(s), including laminotomy, partial facetectomy, foraminotomy, discectomy and/or excision of herniated intervertebral disc, 1 interspace, lumbar


name: Repair of retinal detachment, including drainage of subretinal fluid when performed


name: Repair of retinal detachment, including drainage of subretinal fluid when performed; cryotherapy


name: Repair of retinal detachment, including drainage of subretinal fluid when performed; photocoagulation


name: Unlisted Service or Procedure (Radiology)


name: Supervision and Interpretation (Radiology)


name: Administration of Contrast Material(s) (Radiology)


name: Ultrasound, abdominal aorta, real time with image documentation, screening study for abdominal aortic aneurysm (AAA)


name: Diagnostic mammography, including computer-aided detection (CAD) when performed


name: Separate or Multiple Procedures (Pathology and Laboratory)


name: Unlisted Service or Procedure (Pathology and Laboratory)


name: Special Report (Pathology and Laboratory)


name: Drug test(s), presumptive, any number of drug classes, any number of devices or procedures; capable of being read by direct optical observation only (eg, utilizing immunoassay [eg, dipsticks, cups, cards, or cartridges]), includes sample validation when performed, per date of service


name: Drug test(s), presumptive, any number of drug classes, any number of devices or procedures; read by instrument assisted direct optical observation (eg, utilizing immunoassay [eg, dipsticks, cups, cards, or cartridges]), includes sample validation when performed, per date of service


name: Drug test(s), presumptive, any number of drug classes, any number of devices or procedures; by instrument chemistry analyzers (eg, utilizing immunoassay [eg, EIA, ELISA, EMIT, FPIA, IA, KIMS, RIA]), chromatography (eg, GC, HPLC), and mass spectrometry either with or without chromatography, (eg, DART, DESI, GC-MS, GC-MS/MS, LC-MS, LC-MS/MS, LDTD, MALDI, TOF) includes sample validation when performed, per date of service


name: SEPT9 (Septin9) (eg, colorectal cancer) promoter methylation analysis


name: Cardiac ion channelopathies (eg, Brugada syndrome, long QT syndrome, short QT syndrome, catecholaminergic polymorphic ventricular tachycardia)


name: Cardiac ion channelopathies (eg, Brugada syndrome, long QT syndrome, short QT syndrome, catecholaminergic polymorphic ventricular tachycardia); genomic sequence analysis panel, must include sequencing of at least 10 genes, including ANK2, CASQ2, CAV3, KCNE1, KCNE2, KCNH2, KCNJ2, KCNQ1, RYR2, and SCN5A


name: Cardiac ion channelopathies (eg, Brugada syndrome, long QT syndrome, short QT syndrome, catecholaminergic polymorphic ventricular tachycardia); duplication/deletion gene analysis panel, must include analysis of at least 2 genes, including KCNH2 and KCNQ1


name: Fetal chromosomal microdeletion(s) genomic sequence analysis (eg, DiGeorge syndrome, Cri-du-chat syndrome), circulating cell-free fetal DNA in maternal blood


name: Hereditary cardiomyopathy (eg, hypertrophic cardiomyopathy, dilated cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy), genomic sequence analysis panel, must include sequencing of at least 5 cardiomyopathy-related genes (eg, DSG2, MYBPC3, MYH7, PKP2, TTN)


name: Oncology (high-grade prostate cancer), biochemical assay of four proteins (Total PSA, Free PSA, Intact PSA, and human kallikrein-2 [hK2]), utilizing plasma or serum, prognostic algorithm reported as a probability score


name: Heavy metal (eg, antimony, arsenic, barium, beryllium, bismuth, gadolinium, mercury); qualitative, any number of analytes


name: Testosterone; bioavailable, direct measurement (eg, differential precipitation)


name: Infectious agent detection by nucleic acid (DNA or RNA); central nervous system pathogen (eg, Neisseria meningitidis, Streptococcus pneumoniae, Listeria, Haemophilus influenzae, E. coli, Streptococcus agalactiae, enterovirus, human parechovirus, herpes simplex virus type 1 and 2, human herpesvirus 6, cytomegalovirus, varicella zoster virus, Cryptococcus), includes multiplex reverse transcription, when performed, and multiplex amplified probe technique, multiple types or subtypes, 12-25 targets


name: Unlisted Service or Procedure (Medicine)


name: Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.25 mL dosage, for intramuscular use


name: Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.5 mL dosage, for intramuscular use


name: Influenza virus vaccine, trivalent (IIV3), split virus, 0.25 mL dosage, for intramuscular use


name: Influenza virus vaccine, trivalent (IIV3), split virus, 0.5 mL dosage, for intramuscular use


name: Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, preservative and antibiotic free, 0.5 mL dosage, for intramuscular use


name: Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.25 mL dosage, for intramuscular use


name: Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use


name: Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.25 mL dosage, for intramuscular use


name: Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use


name: Fluorescein angiography and indocyanine-green angiography (includes multiframe imaging) performed at the same patient encounter with interpretation and report, unilateral or bilateral


name: Endoluminal imaging of coronary vessel or graft using intravascular ultrasound (IVUS) or optical coherence tomography (OCT) during diagnostic evaluation and/or therapeutic intervention including imaging supervision, interpretation and report


name: Percutaneous transcatheter closure of paravalvular leak


name: Percutaneous transcatheter closure of paravalvular leak; initial occlusion device, mitral valve


name: Percutaneous transcatheter closure of paravalvular leak; initial occlusion device, aortic valve


name: Percutaneous transcatheter closure of paravalvular leak; each additional occlusion device (List separately in addition to code for primary procedure)


name: Administration of patient-focused health risk assessment instrument (eg, health hazard appraisal) with scoring and documentation, per standardized instrument


name: Administration of caregiver-focused health risk assessment instrument (eg, depression inventory) for the benefit of the patient, with scoring and documentation, per standardized instrument


name: Application of on-body injector (includes cannula insertion) for timed subcutaneous injection


name: Physical therapy evaluation: low complexity, requiring these components: A history with no personal factors and/or comorbidities that impact the plan of care; An examination of body system(s) using standardized tests and measures addressing 1-2 elements from any of the following: body structures and functions, activity limitations, and/or participation restrictions; A clinical presentation with stable and/or uncomplicated characteristics; and Clinical decision making of low complexity using standardized patient assessment instrument and/or measurable assessment of functional outcome. Typically, 20 minutes are spent face-to-face with the patient and/or family.


name: Physical therapy evaluation: moderate complexity, requiring these components: A history of present problem with 1-2 personal factors and/or comorbidities that impact the plan of care; An examination of body systems using standardized tests and measures in addressing a total of 3 or more elements from any of the following: body structures and functions, activity limitations, and/or participation restrictions; An evolving clinical presentation with changing characteristics; and Clinical decision making of moderate complexity using standardized patient assessment instrument and/or measurable assessment of functional outcome. Typically, 30 minutes are spent face-to-face with the patient and/or family.


name: Physical therapy evaluation: high complexity, requiring these components: A history of present problem with 3 or more personal factors and/or comorbidities that impact the plan of care; An examination of body systems using standardized tests and measures addressing a total of 4 or more elements from any of the following: body structures and functions, activity limitations, and/or participation restrictions; A clinical presentation with unstable and unpredictable characteristics; and Clinical decision making of high complexity using standardized patient assessment instrument and/or measurable assessment of functional outcome. Typically, 45 minutes are spent face-to-face with the patient and/or family.


name: Re-evaluation of physical therapy established plan of care, requiring these components: An examination including a review of history and use of standardized tests and measures is required; and Revised plan of care using a standardized patient assessment instrument and/or measurable assessment of functional outcome Typically, 20 minutes are spent face-to-face with the patient and/or family.


name: Occupational therapy evaluation, low complexity, requiring these components: An occupational profile and medical and therapy history, which includes a brief history including review of medical and/or therapy records relating to the presenting problem; An assessment(s) that identifies 1-3 performance deficits (ie, relating to physical, cognitive, or psychosocial skills) that result in activity limitations and/or participation restrictions; and Clinical decision making of low complexity, which includes an analysis of the occupational profile, analysis of data from problem-focused assessment(s), and consideration of a limited number of treatment options. Patient presents with no comorbidities that affect occupational performance. Modification of tasks or assistance (eg, physical or verbal) with assessment(s) is not necessary to enable completion of evaluation component. Typically, 30 minutes are spent face-to-face with the patient and/or family.


name: Occupational therapy evaluation, moderate complexity, requiring these components: An occupational profile and medical and therapy history, which includes an expanded review of medical and/or therapy records and additional review of physical, cognitive, or psychosocial history related to current functional performance; An assessment(s) that identifies 3-5 performance deficits (ie, relating to physical, cognitive, or psychosocial skills) that result in activity limitations and/or participation restrictions; and Clinical decision making of moderate analytic complexity, which includes an analysis of the occupational profile, analysis of data from detailed assessment(s), and consideration of several treatment options. Patient may present with comorbidities that affect occupational performance. Minimal to moderate modification of tasks or assistance (eg, physical or verbal) with assessment(s) is necessary to enable patient to complete evaluation component. Typically, 45 minutes are spent face-to-face with the patient and/or family.


name: Occupational therapy evaluation, high complexity, requiring these components: An occupational profile and medical and therapy history, which includes review of medical and/or therapy records and extensive additional review of physical, cognitive, or psychosocial history related to current functional performance; An assessment(s) that identifies 5 or more performance deficits (ie, relating to physical, cognitive, or psychosocial skills) that result in activity limitations and/or participation restrictions; and Clinical decision making of high analytic complexity, which includes an analysis of the patient profile, analysis of data from comprehensive assessment(s), and consideration of multiple treatment options. Patient presents with comorbidities that affect occupational performance. Significant modification of tasks or assistance (eg, physical or verbal) with assessment(s) is necessary to enable patient to complete evaluation component. Typically, 60 minutes are spent face-to-face with the patient and/or family.


name: Re-evaluation of occupational therapy established plan of care, requiring these components: An assessment of changes in patient functional or medical status with revised plan of care; An update to the initial occupational profile to reflect changes in condition or environment that affect future interventions and/or goals; and A revised plan of care. A formal reevaluation is performed when there is a documented change in functional status or a significant change to the plan of care is required. Typically, 30 minutes are spent face-to-face with the patient and/or family.


name: Athletic training evaluation, low complexity, requiring these components: A history and physical activity profile with no comorbidities that affect physical activity; An examination of affected body area and other symptomatic or related systems addressing 1-2 elements from any of the following: body structures, physical activity, and/or participation deficiencies; and Clinical decision making of low complexity using standardized patient assessment instrument and/or measurable assessment of functional outcome. Typically, 15 minutes are spent face-to-face with the patient and/or family.


name: Athletic training evaluation, moderate complexity, requiring these components: A medical history and physical activity profile with 1-2 comorbidities that affect physical activity; An examination of affected body area and other symptomatic or related systems addressing a total of 3 or more elements from any of the following: body structures, physical activity, and/or participation deficiencies; and Clinical decision making of moderate complexity using standardized patient assessment instrument and/or measurable assessment of functional outcome. Typically, 30 minutes are spent face-to-face with the patient and/or family.


name: Athletic training evaluation, high complexity, requiring these components: A medical history and physical activity profile, with 3 or more comorbidities that affect physical activity; A comprehensive examination of body systems using standardized tests and measures addressing a total of 4 or more elements from any of the following: body structures, physical activity, and/or participation deficiencies; Clinical presentation with unstable and unpredictable characteristics; and Clinical decision making of high complexity using standardized patient assessment instrument and/or measurable assessment of functional outcome. Typically, 45 minutes are spent face-to-face with the patient and/or family.


name: Re-evaluation of athletic training established plan of care requiring these components: An assessment of patient's current functional status when there is a documented change; and A revised plan of care using a standardized patient assessment instrument and/or measurable assessment of functional outcome with an update in management options, goals, and interventions. Typically, 20 minutes are spent face-to-face with the patient and/or family.


name: Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status


name: Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intraservice time, patient younger than 5 years of age


name: Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intraservice time, patient age 5 years or older


name: Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; each additional 15 minutes intraservice time (List separately in addition to code for primary service)


name: Moderate sedation services provided by a physician or other qualified health care professional other than the physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports


name: Moderate sedation services provided by a physician or other qualified health care professional other than the physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports; initial 15 minutes of intraservice time, patient younger than 5 years of age


name: Moderate sedation services provided by a physician or other qualified health care professional other than the physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports; initial 15 minutes of intraservice time, patient age 5 years or older